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Implementation and Evaluation of a Genetic Services Referral Phone Line in the New 
York-Mid-Atlantic Consortium (NYMAC) Region 
 
Alyson Eileen Evans, MS 
 
University of Pittsburgh, 2020 
 
 
 
Abstract 
 
The NYMAC Regional Genetics Network implemented the Genetic Services Referral 
Phone Line in August 2018 with the goal of improving access to genetic services for medically 
underserved populations. During the first year, the phone line was under-utilized despite multiple 
marketing efforts to increase awareness amongst individuals and healthcare providers.  
NYMAC staff are tasked with maintaining a regional genetics service directory and 
staffing the phone line. Between August 2018 and February 2020, phone line utilization was 
tracked and analyzed based on phone line call volume, number of callers who were referred to 
relevant genetic services or support resources, and number of individuals who contacted phone 
line staff via email. Online activity related to digital and email marketing campaigns was also 
tracked. Preliminary qualitative interviews were conducted to gauge healthcare provider 
perceptions of genetics and the phone line implementation process.  
The phone line received 67 calls from 51 unique callers and 6 email inquiries between 
August 2018 and February 2020. A total of 16 phone and email inquiries were handled by NYMAC 
staff, providing those inquiring with relevant information for referrals or support resources. The 
initial digital marketing campaign delivered over 10 million impressions in targeted medically 
underserved areas throughout Maryland and Delaware and generated over 30,000 website clicks. 
Andrea L. Durst, M S, DrPH, LCGC  
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The provider email campaign reached more than 48,000 healthcare providers in the region and 
generated 131 website clicks. A subsequent targeted digital marketing campaign launched in New 
York in January 2020 generated over 5,000 website clicks. Provider interviews identified common 
themes in perceived patient and provider barriers, as well as perceived utility of the NYMAC 
phone line and potential future resources.  
As the phone line continues to receive sparse calls, additional analysis of call volume and 
marketing reach is needed in order to guide future implementation efforts. Future studies regarding 
individual or healthcare provider attitudes and beliefs about decreasing barriers and improving 
access to genetic services may be warranted. Improving access to genetic services in medically 
underserved areas is of public health significance, and lessons learned from this project will inform 
future NYMAC efforts to reach individuals in need of genetic services. 
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1.0 Introduction 
With an increasing public health focus on reducing health disparities, improving access to 
genetic services has been a widely discussed issue in recent years. Prior needs assessments and 
surveys of rural populations in various U.S. states have identified perceived barriers to genetic 
services. Both individuals and healthcare providers identify lack of awareness of genetics services 
and physical location of genetic services as barriers to care1, as well as access to genetic 
counselors.2 While strides have been made in developing alternate service delivery models for 
genetic services3, the issue remains that individuals need to be made aware of such services, and 
may need assistance in identifying relevant services. This can be particularly challenging in 
Medically Underserved Areas and Populations (MUA/Ps), areas or populations within the U.S. 
designated by the Health Resources & Services Administration (HRSA) as lacking adequate 
primary care services, with high percentages of the population aged 65 or older and high levels of 
poverty and infant mortality.4  
The New York-Mid-Atlantic Consortium (NYMAC) Regional Genetics Network aims to 
improve access to and awareness of relevant genetic services in the NYMAC region. In order to 
attempt to address some of these barriers to services, including within MUA/Ps, the NYMAC 
Regional Genetics Network implemented the Genetic Services Referral Phone Line in August 
2018. The phone line was created to assist individuals and healthcare providers with locating the 
nearest genetic services provider based on zip code and the type of services needed. Initial phone 
line marketing campaigns targeted individuals in medically underserved areas in Maryland, and 
later Delaware as well as New York, with additional email campaigns targeted towards primary 
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care providers. To date, phone line utilization has been much less than anticipated, despite efforts 
to increase awareness of the phone line among providers and the public.  
This project focused on detailing the implementation process for the NYMAC Regional 
Genetics Network Genetic Services Referral Phone line, as well as conducting an evaluation of 
utilization and effectiveness of the phone line. Results of this project will serve to provide 
information about the strengths and limitations of phone line implementation efforts. Reaching 
medically underserved populations and connecting these individuals with relevant genetics 
services is an important step towards addressing the public health need to improve access to 
healthcare services. Results will guide future NYMAC efforts, and potentially those of other 
Regional Genetics Networks or genetic service providers.  
1.1 Specific Aims 
Aim 1: To describe the implementation process of the NYMAC Genetic Services Referral Phone 
Line.  
Aim 2: To assess low call volume to the NYMAC Genetic Services Referral Phone Line.  
Aim 3: To evaluate the effect of targeted marketing campaigns on NYMAC website activity and 
utilization of the NYMAC Genetic Services Referral Phone Line. 
Aim 4: To identify potential limitations of the NYMAC Genetics Services Referral Phone Line 
implementation process through utilization evaluation and qualitative interviews. 
   3 
2.0 Literature Review 
2.1 Access to Healthcare Services 
2.1.1  Disparities in Healthcare Services 
According to Healthy People 2020, health disparities are differences in health between 
individuals or groups that are “closely linked with social, economic, and/or environmental 
disadvantages.”5 These disparities exist across racial and ethnic groups, special populations, 
gender, disability status, age, socioeconomic status, and location.6 Different geographic locations 
within the U.S. have different levels of morbidity and mortality, with health disparities being 
prominent in both rural and urban areas, each with unique challenges related to healthcare.6 
According to the National Rural Health Association (NRHA), individuals living in rural areas have 
decreased access to physicians in comparison to individuals in urban areas, and on average, also 
have a larger elderly population (aged 65 and older) and lower socioeconomic status.7  
Medically Underserved Areas and Populations (MUA/Ps) are areas or populations within 
the U.S. designated by the Health Resources & Services Administration (HRSA) as lacking 
adequate primary care services, with high percentages of the population aged 65 or older and high 
levels of poverty and infant mortality.4 Based on the NRHA description of the rural healthcare 
climate,7 many areas designated as MUA/Ps may also be considered rural, with some health 
disparities and barriers potentially attributed to workforce shortages8,9.  
A survey of rural hospital CEOs identified physician shortage and workforce needs, with 
an average of over 75% of these CEOs nationwide identifying an overall physician shortage in 
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their hospitals.8 Notably, 100% of the rural CEOs surveyed in the New England to Virginia region 
indicated an overall physician shortage.8 Shortages in at least two primary care specialties 
(including family medicine, internal medicine, and pediatrics) were identified by 70.3% of CEOs 
nationwide, with a higher rate of these shortages in the New England to Virginia region (83.9%).8 
2.1.2  Genetic Service Provider Workforce Shortages 
Workforce shortages also exist within genetics services, with a 2018 workforce study 
suggesting that as genetic testing becomes less expensive and more widely available, the demand 
for genetic services and testing will increase; however, the ability for the genetics providers 
nationwide to meet this demand is limited by a workforce shortage of genetics providers, 
specifically genetic counselors (GCs).9 Using a goal rate of one full-time equivalent (FTE) GC per 
75,000 persons, their model indicated that the shortage of GCs working in direct patient care may 
not be resolved until the year 2030, taking into account the inevitable growth of the profession as 
well as the changing nature of healthcare systems.9 With these results, Hoskovec et al. concluded 
that to address the demand for genetics services and shortage of genetics service providers, focus 
must be put on expanding genetic counseling training programs, exploring ways to involve non-
genetics providers in genetics services, and integrating tools to increase efficiency of practicing 
GCs.9  
A 2003 workforce analysis of American Board of Medical Genetics (ABMG) certified 
medical geneticists in the United States was completed with a 55% response rate.10 Weighing their 
findings for the living and active medical geneticist population at the time (n=1377), Cooksey et 
al. found that approximately 70% of MD geneticists provided direct patient care, with those 
providing patient care spending approximately half of their working time on activities related to 
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patient care.10 Citing a previously published ratio at the time of approximately 3.5  MD clinical 
geneticists per 1 million people in the U.S, the analysis showed variation across regions of the 
United States, with some states averaging 2.0 or less geneticists per 1 million people, and some 
states with no clinical geneticists, suggesting an insufficient supply of medical geneticists in 17 
states acting as a potential barrier to access to genetics services.10   
2.1.3  Barriers to Accessing Genetics Services 
Studies aimed at better understanding the healthcare needs of medically underserved 
populations, including genetics-related needs, can be instrumental in addressing potential barriers 
to accessing services.  In addition to workforce shortages,9–11 barriers to access to genetics services 
for individuals living in MUA/Ps, including rural areas, as well as how to address these barriers 
have also been widely studied in recent years. As a follow-up to Cooksey et al.10, a 2015 needs 
assessment identified several genetic service components which could benefit from resource 
development.11 This needs assessment surveyed 924 genetics professionals and providers to gather 
additional information about aspects of genetic services which could be addressed to improve 
access, which included appointment wait times, underserved populations, and workforce 
shortages.11 Of those surveyed, 43.5% reported geneticist job openings at their institution, with 
100 medical geneticist openings and 200 GC openings reported across institutions.11 The 
assessment reported increased appointment wait times between the Cooksey et al. study and the 
2015 needs assessment; wait times of over 3 months for a nonemergency new patient appointment 
were reported by 10% of respondents in 2003, and increased to over 30% of respondents in 2015.11 
Estimating an updated workforce ratio of 2 clinical geneticists per 1 million people, the assessment 
suggested that increased patient referrals and wait times, paired with a shortage of genetic service 
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healthcare providers greatly reduces patient access to genetic services.11 This needs assessment 
also identified that individuals living in rural areas do not access genetic services, nor do 
individuals who are uninsured or do not speak English.11 Distance to services, lack of genetic 
service providers, and primary care provider recognition and awareness were among identified 
barriers.11 
A needs assessment completed by the Michigan Department of Community Health 
between 2000-2002, targeted individuals with genetic conditions, parents of children with unique 
health concerns, a sickle cell anemia parent support group, a Native American student group, and 
genetics service providers to identify barriers to access to genetic services for these populations, 
as well as potential ways to address the identified barriers.1 Focus group participants identified 
lack of knowledge and awareness of genetic services, by both individuals and providers, as a 
barrier, as well as lack of awareness of personal risk and concern for discrimination.1 Additional 
concerns included workforce shortages, referral coordination, cost, insurance, and distance to 
genetic services.1 Individuals or families affected by genetic or other health concerns reported 
relying heavily on internet resources for information, while individuals who were unaffected 
reported relying on their healthcare providers for information they needed about genetics.1 
Suggestions to improve access to information about genetics and genetic conditions included a 24-
hour hotline and centralized source of necessary information, with focus groups also suggesting 
increased efforts in implementing telemedicine and additional outreach clinics to improve access 
to genetics services for underserved populations.1 
A recent survey of individuals living in rural Illinois communities captured identified gaps 
in knowledge, attitudes, and perceived barriers to access to genetic testing in relation to cancer 
genetics.2 Individuals surveyed lived in “isolated communities,” or towns with populations of 
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approximately 1500 persons which were 20 or more miles away from a larger town (defined as 
having a population of over 5000 persons).2 69% of these individuals were aware that genetic 
services were available in the context of cancer genetics, while 46% were aware that genetic 
services are available for other, non-cancer conditions.2 In addition, a little less than half of those 
surveyed noted that not having GCs or genetic services close to their location was a barrier to 
services.2  
Barriers to genetic services have been identified in racial and ethnic minority groups as 
well.12 In an analysis by Suther and Kiros, national representative sample data were obtained and 
analyzed to identify and predict potential barriers to genetic testing as they relate to racial and 
ethnic healthcare disparities.12 In comparison to 63.5% of non-Hispanic white individuals, 43.8% 
and 48.7% of Black and Latino individuals, respectively, knew someone having a child “born with 
a genetic defect.”12 This analysis also showed an association between race/ethnicity and genetic 
testing knowledge, with the odd of Black and Latino individuals having appropriate knowledge 
was 28% and 52% lower, respectively, than non-Hispanic white individuals.12 Individuals 
identifying as Black or Latino were also more likely to be concerned about misuse of genetic 
testing, with this concern being 66% and 58% higher in Blacks and Latinos, respectively, in 
comparison to non-Hispanic whites.12 Overall, data analysis suggested that minority groups are 
less likely to utilize genetic services due to barriers which include lack of knowledge, as well as 
lack of physician-provided information, health insurance coverage, and distrust of healthcare 
providers and the medical system.12 
A 2012 study interviewed 120 at-risk Latina women in the New York City area with a 
suggestive personal and/or family history of cancer and no prior genetic counseling or testing to 
assess perceived barriers and perceptions of genetic counseling for BRCA1/2-related indications.13 
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More than half of the women interviewed had relatively little or almost no awareness of the 
availability of genetic counseling for hereditary conditions or cancer, and nearly half of those 
interviewed had little awareness about genetic counseling for breast and ovarian cancer.13 Over 
one third of participants identified competing health or life concerns as a barrier to pursuing BRCA-
related genetic counseling, with the majority of those interviewed sharing logistical concerns, 
including uncertainty of where to go for genetic counseling, time constraints, and insurance 
coverage.13 
In a study completed by Mountcastle-Shah and Holtzman, 60 primary care providers across 
four specialties (pediatrics, obstetrics, family medicine, and internal medicine) were interviewed 
regarding perceived barriers of integration of genetics into their practice.14 Respondents discussed 
lack of demonstrated clinical utility of testing as the most common barrier, with 60% of providers 
stating they would show some hesitation to order a genetic testing without an adequate 
understanding of how it would affect patient care.14 Additional barriers identified included clinical 
validity, cost, and concern for loss of insurance coverage.14 
Barriers to genetic services as perceived by primary care providers were further explored 
in a 2003 review completed by Suther and Goodson.15 Across 18 publications, the most common 
barrier identified was provider lack of knowledge of genetics and genetic testing and counseling.15 
Suther and Goodson comment that while this is the most commonly cited barrier, it may be based 
on the potentially problematic assumption that providers’ lack of knowledge is “undesirable,” 
suggesting that rather, the perceived lack of knowledge should be explored further to determine if 
this lack of knowledge translates to uncertainty surrounding genetic testing.15 Other commonly 
identified barriers included lack of or outdated family history information, lack of referral 
guidelines, decreased confidence amongst providers, and insurance or financial concerns.  
   9 
A 2015 review by Delikurt et al. also identified barriers to patient referral to genetic 
services.16 Reviewing nine publications, barriers related to both individuals and healthcare 
providers were identified.16 Individual barriers to genetic services identified by Beene-Harris et 
al.1 were summarized, including lack of personal risk awareness, lack of knowledge of family 
medical history, and lack of knowledge of available genetic services, the latter of which was 
reported in two additional publications.16 In regard to healthcare providers, perceived barriers to 
patient access included lack of adequate family history and lack of provider knowledge of genetics 
and awareness of genetic services.16 Additional barriers related to healthcare providers were lack 
of awareness of patient risk, referral coordination issues, and genetic workforce shortages.16 
From the genetic service provider standpoint, similar barriers to access to genetics services 
have been identified. In a survey of 28 genetic service providers from across the U.S. (GCs and 
medical geneticists), 72% of respondents noted that pursuing cancer genetic counseling was not 
an apparent priority for patients.17 52% of providers cited patient concerns regarding insurability, 
and 44% also noted lack of insurance coverage as perceived patient barriers to cancer genetic 
counseling services.17 Nearly half (48%) of the survey respondents reported distance to genetics 
services as a perceived patient barrier, and 36% included lack of knowledge about or understanding 
of genetic counseling by both patients and other healthcare providers as an additional patient 
barrier.17 Additional perceived barriers included patients being discouraged by family members, 
fear of results and their impact on a patient’s family or employment, and lack of time.17 This 
study’s respondents also provided suggestions for addressing these potential barriers, with the 
majority (70%) suggesting increased provider education.17 
In a study interviewing 6 GCs working in rural areas, the GCs shared that they see diverse 
populations, including elderly populations and individuals from “economically diverse” 
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backgrounds and individuals with rare conditions.18 They identified that the distance patients must 
travel to an appointment, lack of awareness of genetic conditions, the availability of genetic 
services, providers lacking knowledge of when to make an appropriate referral, and lack of clinical 
geneticists are potential barriers to patients accessing genetics services.18 GCs practicing in rural 
areas have also identified several factors which may decrease some barriers to genetics services 
for rural and underserved populations, including professional resources and support systems, 
adapting clinic schedules and availability and adding outreach clinic locations to meet the needs 
of the unique population they serve, and implementing alternate service delivery models.18 
2.1.4  Alternate Service Delivery Models 
With increased demand for genetic services and genetic testing in a genetics workforce 
shortage climate, implementation and evaluation of alternative service delivery models is 
necessary in order to improve access to genetics services.19 Traditional models of genetic 
counseling, which are often in-person and often require a significant amount of time pre-, during, 
and post-session, may not support increased patient access and/or GC efficiency, and thus, many 
GCs have adopted additional alternate service delivery models.3,19 Multiple service delivery 
models have been developed as a way to address the various identified barriers to genetic services, 
including telegenetics and telephone genetic counseling options to improve access for individuals 
located a far distance from genetics services, genetic counseling assistants to assist with decreasing 
wait times for genetic counseling appointments, and group genetic counseling and use of genetic 
counseling extenders to address the workforce shortage of GCs.3  
To assess the support for and utility of group genetic counseling, a 2017 study described 
the experiences and successes of group genetic counseling in a prenatal setting.20 In the study, 172 
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women referred for prenatal genetic counseling following positive serum screening for Down 
syndrome were systematically assigned to an individual genetic counseling appointment (37.8%) 
or group genetic counseling appointment (62.2%).20 Group genetic counseling sessions were made 
up of 2-6 patients, as well as their partners, and one GC, with participants having the option to stay 
for an individual meeting with the GC following the group session.20 Using pre- and post-
counseling questionnaires, Cloutier et al. were able to asses patient anxiety, knowledge, and 
satisfaction.20 This study found a significant decrease in patient anxiety and decisional conflict, as 
well as an increase in perceived personal control and knowledge scores for all study participants 
who received genetic counseling, with similar patient satisfaction in both service delivery 
models.20 Significant differences were not shown between study groups in assessments of 
perceived personal control, decisional conflict, or knowledge; however, those who had received 
individual genetic counseling were found to have significantly decreased anxiety as compared to 
those who received group counseling and the GC spent less time per group patient compared with 
time spent with individual patients.20 These findings suggest that group counseling may be an 
acceptable approach to providing genetic counseling to patients; however, 85% of group genetic 
counseling patients elected to stay after the group session for an individual discussion with the GC, 
suggesting the importance of the availability of individualized counseling.20 This study highlights 
that group genetic counseling is feasible and can increase the time efficiency of GCs, which can 
increase access by allowing more patients to be seen by a genetic service provider, but limitations 
do need to be acknowledged.20  
While not a formal service delivery model, the addition of genetic counseling assistants 
(GCAs) to genetics practices has been suggested as another potential solution to increasing patient 
access and clinic efficiency, as described in a 2018 study by Hnatiuk et al.21 Following a survey 
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of 271 GCs, including those who had worked with GCAs previously and those who had not, GCAs 
were determined to primarily perform clerical (93%) or administrative tasks  (83%) and data entry, 
with a smaller number of GCs (< 20%) reporting working with GCAs carrying out more clinically 
involved tasks, such as test coordination, letter or report writing, and calling out test results.21 
Using open ended questions, study participants were able to comment on GC and clinic efficiency, 
stating that GCA integration into their institutions allowed GCs to spend more time on tasks for 
which they were specifically trained, which allowed more patients to be seen and overall, 
increasing patient access to genetic services.21 This assessment advises that GCAs are not a single 
solution to increasing patient access; however, adoption of other alternate service delivery models 
in addition to GCA integration can maximize this efficiency and increase access.21  
In a 2013 report by the National Society of Genetic Counselors (NSGC) Service Delivery 
Model Task Force, 54.7% of survey respondents reported using only traditional genetic counseling 
models in practice; however, the remainder of respondents reported adoption of at least one 
alternate service delivery models, including telephone genetic counseling, group genetic 
counseling sessions, and telegenetics.19 Telegenetics, or telemedicine, is typically understood to 
be a genetics services consultation completed via video and audio connection, providing a benefit 
for individuals who may live in an areas without genetics services available, or who are unable to 
travel to an area with genetics services available.22 Among a survey of self-identified telegenetics 
programs in seven states within the New York-Mid-Atlantic region and Washington, D.C., 
respondents reported increased patient access through decreased wait times, increases in the 
number of patients seen per month, and a geographic reach of over 200 miles.22  These survey 
respondents reported that telegenetics services were particularly successful in reaching individuals 
who otherwise may not have been able to access genetics services.22  
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A 2015 study by Buchanan et al. describes a random trial to assess telegenetics services in 
cancer genetic counseling.23 In the trial, 162 patient participants were randomized to receive 
genetic counseling at a local rural oncology clinic or via telegenetics, with subsequent assessments 
of cost, attendance, and patient satisfaction.23 Telegenetics consultations were found to be more 
cost efficient, with a per-patient cost that was $138.14 less than in-person genetic counseling.23 
Post-appointment surveys showed no significant difference in patient satisfaction between those 
who had telegenetics appointments and those who did not; however, study participants were more 
likely to attend an in person appointment (89%) versus a telegenetics appointment (79%).23  These 
findings suggest that telegenetics may be a feasible and cost-effective way for clinics to increase 
access to genetic counseling; however, it should be noted that telegenetics may still not be an 
appropriate solution to reach all underserved populations.23  
Alternate service delivery models, including telegenetics, will likely be imperative to 
linking more individuals with genetics service providers in the future, by helping to decrease 
barriers affecting genetic service utilization by patients and healthcare providers.3 It will be 
important; however, to better understand how to increase awareness of the availability of such 
service delivery models. The increasing availability and successful integration of alternate service 
delivery models will not only address barriers to individuals accessing genetics services, but may 
also lend to more streamlined integration of genetics into primary care practice in the future.3  
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2.2 Genetics in a Primary Care Setting 
2.2.1  The Role of the Primary Care Provider 
A primary care provider (PCP) has been defined as a provider “who provides, coordinates, 
or helps a patient access a range of health care services.”24 According to the Institute of Medicine 
(IOM) Committee on the Future of Primary Care, primary care encompasses care provided by 
providers who “are accountable for addressing a large majority of personal health care needs, 
developing a sustained partnership with patients, and practicing in the context of family and 
community.”25 Primary care has extended beyond duties of doctors of medicine (MDs) and doctors 
of osteopathic medicine (DOs) practicing in family or internal medicine, pediatrics, and obstetrics 
and gynecology to also include non-physician clinicians, including nurse practitioners (NPs) and 
physician assistants (PAs).25 
PCPs serve as a central point of contact for their patients, providing long-term care for a 
variety of medical concerns and promoting overall health and wellness, while also providing a link 
to the broader health care system.26 PCPs regularly use referrals to connect their patients to 
specialty care to address more complex or specific healthcare needs,26 with genetics being included 
in such specialty care. With the increasing demand for genetic services and the workforce shortage 
of genetics healthcare providers, the integration of genetics into primary care is becoming an 
important component of healthcare.27 PCPs and other key informants within one health system 
have acknowledged that it is a PCPs duty to facilitate relevant genetic care for their patients, with 
one PCP stating their role as identifying genetic conditions and placing an appropriate referral.27  
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2.2.2  Genetics Education for Primary Care Providers 
Medical education is typically structured with both didactic coursework and clinical 
experiences and skill development, with didactic courses emphasizing basic biomedical concepts, 
as well as keeping current with advances in the field, such as chronic illness, geriatrics, and  
population health.28 Medical school curriculum is governed by each specific institution, with 
general competencies used to guide curriculum development, but no standardized coursework 
implemented across institutions.28 Similar competencies have been developed for PAs29 and 
NPs29,30. This likely accounts for differences in the amount and type of genetics education a PCP 
in training may experience. According to the Association of American Medical Colleges (AAMC), 
approximately 19% of medical schools’ curricula in 2017-2018 included an independent genetics 
course.31 More commonly, genetics has been increasingly taught as part of an integrated course, 
incorporated with other topics in which genetic conditions may be relevant.31 However, it has been 
estimated that genetics makes up an average of 2% of the didactic content at AAMC member 
institutions.32    
The Core Competency Working Group of the National Coalition for Health Professional 
Education in Genetics (NCHPEG) was established in the early-2000s to address potential gaps in 
genetics education for all types of healthcare providers.33 These core competencies include 
knowledge of basic genetics concepts, ability to gather and assess family medical history, capacity 
to provide patients with education and relevant resources, and recognition of perspectives which 
influence genetic services and testing.33 While the competencies were created as a resource to 
encourage providers to address gaps in genetics knowledge, the NCHPEG recommends that, at a 
minimum, all healthcare providers should be able to recognize the limitations of their genetic 
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knowledge, understand the implications of genetics, and know when to refer their patients to an 
appropriate genetics provider and how to facilitate such referrals.33  
Similarly, the Association of Professors of Human and Medical Genetics (APHMG) have 
developed a core curriculum for competency-based genetics education in medical schools.34 
Taking into account the changing landscape of genomic medicine as a whole, the core curriculum 
incorporates emerging topics of which all medical school graduates should have knowledge.34 The 
APHMG curriculum were developed as a framework that will allow medical schools to incorporate 
genetics education in a variety of ways, including standalone or integrated coursework.34  
Assessment of historical and current genetics integration within medical education has 
consistently shown that PCPs find their genetics education to be lacking.32,35–37 A 2008 study 
among individuals in family medicine residency programs showed that residents had learned about 
genetics early in their medical education, and typically in the context of rare diseases, making it 
difficult for these individuals to find relevance for genetics in everyday clinical practice.36 It was 
also noted that during residency, genetics was primarily encountered in pediatrics and obstetrics, 
so these specialties become more associated with genetics.36 Suggestions have been made that 
medical education should broaden the scope of genetics integration, framing genetics beyond the 
context of rare conditions, with more consistency between institutions.27 It has also been suggested 
that concepts should be taught in the context of clinical cases and that genetics should remain a 
separate course in medical school curriculum in order to increase provider knowledge.37  
In a survey of 112 medical genetics course directors at medical schools in the United States 
and Canada, Plunkett-Rondeau et al. determined that 75% of schools taught the majority of their 
genetics curriculum in the first year of medical school, with only 26% reporting formal genetics 
education in the last two years of medical school.32 In this survey, genetics was found to be a 
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standalone course at 25% of schools, with it being more common for genetics to be integrated with 
other science content, such as biochemistry, and 7% of schools integrating genetics content with 
clinically relevant topics.32 Over half of respondents (60%) reported using the APHMG core 
curriculum to guide curriculum content and development at their institution.32 
A 2012 report by Baylor College of Medicine (BCM) details efforts to increase genetics 
exposure for their medical students within their institution.38 Utilizing an existing “track” system, 
in which medical students can personalize their education, BCM has established the Genetics 
Track Curriculum (GTC).38 Establishment of GTC resulted in the addition of several genetics 
electives to the BCM curriculum, and while the GTC is aimed at medical students who wish to 
gain more knowledge and experience specifically with genetics and genomics, courses are 
available to any medical student.38 GTC courses span across all four years of medical school and 
allows students to build upon foundational genetics concepts, enhance their clinical experience, 
and gain a better understanding of clinical diagnostics and patient experience.38 Dhar et al. suggest 
that development of this specialized curriculum within BCM can not only enhance the educational 
experience of those who wish to become medical geneticists, but can also provide a greater breadth 
of education so that those training in other specialties, such as primary care or internal medicine, 
can be equipped to provide better patient care and personalized medicine in their practice.38 
In a recent special report, Hyland, Garber, & Dasgupta detail genetics-related efforts in 
medical education.39 In addition to medical schools’ efforts to engage students, further integrate 
genomics into curriculum, and expand genetics education across all years of medical school, the 
report describes initiatives by professional organizations, including APHMG, Association of 
Pathology Chairs Undergraduate Training in Genomics working group, and ACMG.39 These 
organizations have all developed and continue to work on developing teaching resources and 
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educational activities, peer-reviewed resources, adaptable lesson plans, and extracurricular 
programs for medical students, including ACMG sponsored student interest groups (SIGs) and a 
summer program which allows medical students to gain clinical genetics experience.39 Hyland, 
Garber, & Dasgupta acknowledge the availability of genetics- and genomics-focused continuing 
medical education (CME) opportunities for healthcare providers; however, to further address gaps 
in genetics education, they suggest enlisting the help of “genomics champions,” or individuals 
with genomics knowledge within their specific practice specialty who can educate and coach 
others.39  
2.2.3  Primary Care Providers’ Perceptions of Genetics 
As genetics becomes an increasingly prevalent topic in today’s society, and a more 
integrated part of contemporary healthcare, it is important to address how the topic of genetics fits 
into the role of the primary care provider. There has been widespread interest in ascertaining 
providers’ perceptions of genetics, with multiple research approaches being used to elicit provider 
understanding, concerns, and suggestions regarding integration of genetics into primary care 
practice.40–44 Concerns remain about PCP readiness to integrate genetics into their practice, as 
PCPs have self-identified themselves as having limited genetics knowledge and educational 
background.35,40 
A pervasive concern amongst PCPs is that they do not know enough about genetics and/or 
genetic testing, and that they do not feel prepared to answer questions that patients may have about 
these topics. A study published by Harding et al. in 2018 focuses on PCPs’ experiences with 
genetics following 10 interviews and 5 focus groups with PCPs and other key informants in rural 
and urban locations within Canada.40 In regard to their experiences with genetics in practice, both 
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rural and urban PCPs shared having more genetics exposure in the prenatal and cancer settings, 
and considered genetic information to be beneficial.40 PCP participants had experience ordering 
genetic testing for common indications; however, concerns arose regarding further integration of 
genetics into future primary care practice without appropriate support for PCPs.40 It was noted that 
PCPs’ lack of genetics knowledge may impact decision-making regarding genetics referrals for 
their patients, with a need for more education, resources, and PCP support.40 Participating PCPs 
suggested a need for further continuing education options, including updates via email and mail, 
print resources such as pamphlets, and an online genetic condition database.40 Those in rural 
locations also expressed interest in having easy access to a genetics expert via phone or email.40 
Providers reportedly acknowledge that genetics is becoming part of primary care practice, but feel 
that keeping up to date with genetics knowledge is “tricky,” and additional barriers influence PCP 
reports that they are not prepared for their potential roles in regard to integrating genetics in their 
practice.40 Concerns were raised that genetics may be outside of the scope of primary care practice, 
with identified barriers including the availability of funding to establish PCP resources, location 
and travel limitations, lack of understanding and knowledge of particular conditions and test result 
implications, and patient apprehension.40 Of note, those in rural locations also described a 
phenomenon in which individuals living in rural areas “learn to manage without” certain healthcare 
services, and when these services become available to them, the perceived utility may be low.40  
An Australian needs assessment completed by Metcalfe et al. identified similar provider 
concerns during focus group interviews with 39 general practitioners (GPs) from a variety of 
clinical specialties and geographical areas.35 GP participants shared that often they discuss genetics 
with patients only in specific high risk scenarios, such as advanced maternal age in pregnancy or 
suggestive ethnic background or family history, with one GP concerned that patients often present 
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knowing more information about a particular genetic condition than the GP does.35 GPs raised 
concerns about patient psychosocial responses related to genetic testing, as well as GP ability to 
explain concepts in lay language or appropriately convey risks.35 GP educational concerns were 
an additional theme amongst focus group participants, with GP knowledge level found to be 
dependent on the timeline of their medical education.35 Providers noted difficulties in keeping up 
to date with genetic developments, and that additional knowledge was often learned in context of 
clinical experiences.35 It was noted that efforts surrounding GP genetics education would likely 
improve knowledge, with GPs suggesting distance education opportunities, case-based seminars, 
electronic and print resources, as well as a telephone hotline/advisory service as potential sources 
of information related to genetics.35 
Concerns repeatedly arise that providers do not receive adequate genetics education in their 
training, with a study by Lopes-Júnior et al. reporting that 57.4% of PCPs and nurses surveyed 
(n=54) did not feel that their undergraduate genetics education was relevant to their clinical 
practice.45 Of those surveyed, 72.2% were aware of the importance of genetic counseling; 
however, 62.9% were unaware of institutions that offered genetic counseling services.45 The 
majority of PCPs and nurses surveyed had participated in the care of an individual with a genetic 
condition, but 77.8% shared being unprepared to care for these individuals.45 33.3% of respondents 
were unsure of how and where to refer patients and over 90% of respondents indicated they had 
not had any training in genetic screening or genetic counseling, with only 27.7% of those surveyed 
demonstrating appropriate genetic counseling knowledge.45 
This perceived lack of knowledge has been identified as a barrier to patients receiving 
genetics services, impacting PCPs’ ability to recognize appropriate patients to refer to genetics41, 
as well as their ability to identify resources that can assist them.43 In a qualitative study of 51 PCPs, 
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Carroll et al. identified limited exposure to personalized medicine, with most having experience in 
the realm of hereditary breast cancer or the prenatal setting.41 Lack of knowledge was a recurring 
theme in interviews, with providers expressing anxiety and apprehension regarding discussion of 
personalized medicine with patients.41 Some PCPs also shared that their attitudes and perceptions 
were shaped by personal experience, with personal feelings influencing discussions with patients.41 
PCP participants in this study also identified uncertainty in when to make referrals and lack of 
relationships with genetics professionals as barriers.41 The study identified PCP needs related to 
personalized medicine, including more education and information about screening management, 
treatment, referral guidelines, available genetic tests and information about cancer genetics, and 
genetic testing benefits.41  PCPs also identified resource needs, such as point-of-care tools, updated 
and reliable information sources, educational sessions, and resources within clinic, such as a go-
to person or resource who could answer their questions related to genetics-related care for their 
patients.41 
In an online survey of 88 PCPs recruited from the American Academy of Pediatrics’ 
Quality Improvement Innovation Networks, Rinke et al. aimed to identify PCP current practices 
and attitudes surrounding genetics.43 The majority of respondents reported ordering genetic testing 
zero to three times annually, with an average of 4.8 patients per year referred for genetics 
evaluation.43 Of those surveyed, 89% reported having access to a genetics professional, with 75% 
reporting these professionals are located 30 miles or less from their practice.43 Less than half of 
PCPs felt competent providing genetics care to patients, with 94% respondents indicating that an 
increased understanding of genetics would allow them to more effectively integrate genetics into 
practice.43 59% of respondents reported that they did not have adequate resources to determine 
when to order an appropriate genetic test, and 42% of respondents in the study were aware of < 1 
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national resources for genetic services and information. Rinke et al. suggest that provider 
education, leveraging existing provider resources, and increasing access to genetic services could 
improve the diagnosis and care of children with genetic conditions.43 
Providers have identified physical barriers to access to genetic services for their patients as 
well, stating that they have no established relationships with GCs or genetics providers to refer 
to41,44 or lack GCs in the area in which they practice44. Of note, Diamonstein et al. found that of 
the providers in their study who reported no GCs in their area, one-third of these providers had 
GCs practicing within 10 miles of their practice location, indicating the importance of increased 
education and making providers aware of genetic services and GCs in their area.44 Additional 
barriers that have been identified by PCPs include concern for patients’ mental health, insurance 
discrimination, and cost.42  
In addition to barriers attributed to genetic knowledge and availability of genetics service 
providers, PCPs have also acknowledged struggles related to “direct to consumer (DTC)” genetic 
testing41, or genetic testing which can be initiated by a patient/consumer with or without prior 
consultation with a healthcare provider or genetics specialist. PCPs have shared that they feel they 
have very little knowledge about DTC testing, and have gone as far as to describe it as “scary.”41 
In a study completed by DTC genetic testing company 23andMe, 130 PCPs were surveyed 
regarding attitudes and perceptions of DTC testing.46 Just over one quarter of PCPs surveyed felt 
comfortable with their knowledge and ability to help patients understand DTC genetic test results 
prior to completing DTC genetic testing themselves as part of the study.46 With patients taking on 
a more active role in their healthcare and medical decision-making, DTC approaches for genetics, 
as well as other aspects of healthcare, will provide unique challenges to the changing landscape of 
primary care.47 
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2.3 Hotline Availability and Evaluation Studies 
Telephone call centers or hotlines have been long established as resources to connect 
individuals with services in a variety of settings, including healthcare, consumer services, and 
counseling. For example, the Rape, Abuse and Incest National Network (RAINN) has successfully 
implemented both phone and internet-based hotlines with the goal to provide support, advice, and 
advocacy to victims of sexual assault.48 Staffed by trained volunteers with services similar to in-
person rape crisis center services, evaluation of these hotline services has shown that RAINN has 
been able to effectively extend their services to areas and communities which may otherwise lack 
in-person services.48 This service model may also be successful due to the added layer of 
anonymity for callers/users.48 
Studies evaluating the implementation and utilization of hotlines in any setting are critical 
to understanding the effectiveness of the service.49–51 The Department of Veterans Affairs have 
detailed the implementation of a suicide hotline for veterans, describing the challenges of targeting 
veterans, a population which is largely adult males, and which does not fit the typical hotline caller 
demographic.49 This Department of Veterans Affairs hotline was promoted using targeted 
advertising campaigns, including posters on public transit vehicles, and call data correlated with 
an increase in referrals to the department’s suicide prevention group following hotline 
implementation.49  
Hotline evaluation projects can also help in identifying limitations and areas of 
improvement for underutilized hotlines.51,52 The Heath Care Safety Hotline was implemented in 
2014 and designed as a way for consumers to report patient safety concerns in a healthcare 
setting.52 The hotline and an accompanying website were operational for 17 months, implemented 
within two healthcare organizations and staffed by research team members.52 The availability of 
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the hotline was marketed through brochures, hospital websites, and pamphlets provided at time of 
patient discharge; however, the hotline was widely underutilized, with a limited number of calls.52 
Evaluation of hotline webpage traffic showed that more individuals were accessing the website 
than utilizing the website or hotline to make safety reports.52 Schneider et al. note that the outreach 
was expanded and outreach strategies were refined over the 17 month period; however, the report 
volume remained “suboptimal.”52 The group who developed the phone line was able to 
acknowledge the potential of the phone line, and highlighted that the healthcare systems were able 
to use the available data to address the concerns of those who did utilize the reporting system.52 
The study suggests that the implemented hotline prototype can be adapted and can be scalable to 
other settings, and suggests future efforts be directed at evaluation of outreach strategies and online 
platforms as well as sharing hotline materials within a public domain to increase the use of the 
developed prototype and materials.52  
Modifications in hotline implementation have been shown to increase utilization by target 
audiences.53 A German-based medical group developed a hotline for individuals with multiple 
sclerosis (MS) and caregivers of individuals with MS to obtain additional information and 
resources about palliative care.51 This hotline was advertised in a print magazine targeted to the 
MS community, as well as on pamphlets shared with MS caregivers and healthcare providers; 
however, the hotline received only 18 calls during its pilot year.51 The group implementing the 
phone line acknowledged the low call volume, but believed that the fact their hotline was being 
used at all suggested its potential to better serve the MS community.51 Follow-up assessment of 
this same hotline two years after its implementation and expansion to more areas of the country 
showed an increased call volume, with the hotline receiving an additional 222 calls over a 27 
month period, suggesting the hotline is a valuable resource for this target group.53 
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Hotlines are not only designed as a resource for patients and consumers, but can also be 
targeted to healthcare providers, such as the Uliza! HIV hotline based out of Kenya.50 This hotline 
was created to provide consultation services to healthcare providers in rural, under-resourced areas 
of Kenya with a high burden of HIV.50 Available 24-hours per day, 7-days per week, the Uliza! 
hotline was staffed by consulting expert HIV physicians equipped with internet resources and a 
specialist support network and aimed to take advantage of the widespread cell phone use by 
providers in remote areas.50 The hotline was presented to healthcare providers and nurses from 
study sites at a publicity meeting, and the Uliza! group relied on word of mouth, text message 
promotions, and continuous medical education sessions to further advertise the availability of the 
hotline.50  
Following implementation, the Uliza! group completed an evaluation study, assessing the 
utilization of the hotline as well as potential barriers.50 Using a form to capture demographics, 
nature of caller questions, staff responses, and resources utilized during the calls, the group was 
able to assess hotline utilization for the first year of the hotline implementation.50 Surveys of 
hotline users and non-users at study sites were completed at multiple time points to obtain 
feedback, identify barriers to usage, limitations, and future expansion opportunities.50 During its 
first year, the hotline received 296 calls from 79 healthcare providers, with surveys indicating that 
the hotline was helpful in improving quality of care.50 Those that used the hotline noted that poor 
cell phone coverage, slow staff response times, and access to alternate information acted as barriers 
and impacted their hotline use.50 The Uliza! group found that those who had not used the hotline 
indicated they did not know about the hotline availability, did not have a cell phone/coverage, did 
not have questions that required assistance, and had access to alternate resources.50 Most calls to 
the hotline came from study sites with high patient volume and more experience with HIV 
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services.50 Despite barriers identified by users and nonusers, the hotline evaluation by Karari et al. 
suggest potential utility for a telephone based consultation service for resource-limited areas, 
which can have an important role in increasing healthcare provider access to relevant patient care 
information.50  
Within the scope of genetics, current national telephone resources are available from 
Genetic Alliance, a non-profit advocacy organization focusing on individuals and families 
impacted by genetic conditions54; the Genetics and Rare Disease Information Center (GARD), a 
National Institutes of Health sponsored program focused on providing information about genetic 
conditions55; and the National Organization for Rare Disorders (NORD), an organization focused 
on supporting those impacted by rare disorders, as well as organizations dedicated to such 
individuals and families56. These groups all have publicly available phone lines available for 
individuals to call and get information about specific genetic conditions or support resources, 
without providing medical advice.54–56 The availability of such hotlines suggest the potential value 
of phone lines specific to genetics-related questions and concerns; however, there is little 
information available about the utility of  a phone line dedicated to connecting individuals with 
genetic services, rather than disease-specific information. 
2.4 Regional Genetics Networks 
2.4.1  History  
In an effort to work towards improving the health of children and families through the 
intersect of genetics, newborn screening, and public health across the United States, the Maternal 
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and Child Health Bureau (MCHB) of HRSA, Genetic Services Branch (GSB) provided funding 
for the establishment of a National Coordinating Center (NCC) and seven Genetics and Newborn 
Screening Regional Collaborative Groups (RCs) in the United States and United States territories 
in 2004.57 58 These RCs were established in order to meet a need for the availability of a centralized 
group of experts to assist states in the diagnostic and follow-up protocols for state-coordinated 
newborn screening programs.59 The ultimate goal of the RCs was “to enhance and support the 
genetics and newborn screening capacity of the States” through training and educational strategies 
and assisting in improving the infrastructure of newborn screening and follow-up services and 
improve access to genetics services and expertise.60 
In 2017 the RCs were renamed Regional Genetics Networks (RGNs)61, and the goals of 
these RGNs broadened with the most recent funding cycle (June 2017-May 2020), with RGNs 
tasked with the following: 
1) By May 2018, each RGN will provide services to at least 250 individuals or 
families within the geographic area served by the RGN 
2) By May 2020, each RGN will provide services to at least 1,500 individuals 
within the geographic area served by the RGN.  
3) By May 2020, increase by 20 percent the number of medically underserved 
patients served by each RGN.  
4) By May 2020, increase by 20 percent the percentage of clinical sites that use 
telehealth/telemedicine to provide genetic services.  
5) By May 2020, increase by 20 percent the number of medically underserved 
patients receiving genetic services through telemedicine visits.  
6) By May 2020, increase by 20 percent the number of primary care providers 
using RGN resources.62 
 
These RGNs continue to be coordinated by the NCC, which functions to support the RGNs 
through infrastructure development and evaluation, quality improvement efforts, financing and 
technical assistance, and engagement of RGNs and partners.61  In partnership with ACMG, the 
NCC and RGNs collaboratively develop educational resources and work towards improving access 
to genetics services for medically underserved populations.63 
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Under the goals outlined by the NCC, the various RGNs across the United States have 
developed a variety of resources and projects to work toward increasing access to genetic services. 
For example, the Western States RGN (WSRGN) has developed projects to support telegenetics 
implementation and training for healthcare providers, established a mentorship program for 
minority GCs, created resources related to state newborn screening, and funded outreach clinics in 
underserved populations in Alaska, Hawaii, and Guam.64 The New England Regional Genetics 
Network (NERGN) has developed a variety of patient and provider educational resources, as well 
as a web-based services directory for those who visit their website to find genetic services, 
telemedicine locations, family organizations, and public health programs.65 The Southeast 
Regional Genetics Network (SERN) has a variety of resources available, and a similar web-based 
directory.66 The NCC website also hosts a resource repository, in which the NCC, all RGNs, and 
other partners can submit and publicly share resources developed for a variety of purposes and 
audiences, including fact sheets for patients and healthcare providers, educational guides, and 
webinars and educational modules.67 
2.4.2  NYMAC Regional Genetics Network 
One of the seven national RGNs, the New York-Mid-Atlantic Consortium (NYMAC) 
Regional Genetics Network (Figure 1) serves Delaware, District of Columbia, Maryland, New 
Jersey, New York, Pennsylvania, Virginia, and West Virginia.68 NYMAC is based out of the 
Wadsworth Center, New York State Department of Health.69 NYMAC focuses on a variety of 
projects, with a unifying goal of improving access to genetic services, specifically for medically 
underserved populations.70 NYMAC also aims to improve access by increasing the number of 
individuals served overall by the NYMAC RGN, increasing the number of PCPs utilizing 
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NYMAC resources, and increasing telemedicine use in clinical sites and in medically underserved 
populations.70 NYMAC also works closely with family-led organizations to support their efforts 
and act as a resource. These organizations include state specific Parent-to-Parent (P2P) groups,71 
as well as Family-to-Family (F2F) or Family Voices (FV) affiliates,72 family-led groups in which 
one parent or family provides information, resources, and emotional support to families of and 
children with special healthcare needs.  
 
Figure 1. NYMAC Regional Genetics Network Logo 
Many of the individuals served by the NYMAC RGN live within a HRSA-designated 
MUA/P.4 A regional needs assessment showed that many individuals in the NYMAC region live 
below the poverty level, with those individuals from five of the region’s states falling below the 
national average poverty level. Many individuals in the NYAMC region also live in rural areas, 
living in areas with limited healthcare resources and/or living a further distance from specialized 
medical care, which provides an additional barrier to obtaining necessary genetic services within 
the region (NYMAC, unpublished data, 2015). 
Further regional barriers were identified in a 2017 study completed by NYMAC and the 
National Center for Hearing Assessment and Management (NCHAM) that surveyed 266 PCPs 
across the NYMAC region to assess knowledge and use of genetic services in the context of 
children who are deaf or hard of hearing.73 Findings of this study were consistent with similar 
studies of provider perceptions of and barriers to genetics services41,42, with 43% of respondents 
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indicating lack of knowledge and 39% of respondents indicating logistics of referring to genetics 
as barriers to genetic services for their patients.73  
To address the barriers to genetic services identified in both published and internal studies, 
NYMAC implemented the a Genetic Services Referral Phone Line in 2018 to assist patients and 
providers in facilitating genetics appointments or referrals.74 In conjunction with ACMG, NYMAC 
staff compiled a clinical services directory and developed a clinical service location map.75 The 
directory, created by NYMAC to be used internally, and later incorporated into a national ACMG 
directory (https://clinics.acmg.net/), includes information about each clinic site’s location and 
genetic services.75 Trained phone line staff use these resources to provide phone line callers with 
relevant nearby clinic information based on the caller’s location and needs.75  
 By assisting callers in identifying the nearest genetic services location to them, including 
telemedicine options, NYMAC hopes to work towards increased access to genetic services in the 
region.74 In addition to the Genetic Services Referral Phone Line implementation efforts, NYMAC 
has a variety of workgroups addressing healthcare access and insurance coverage, newborn 
screening, primary care education, and public health assessments.76 In order to continue working 
towards improved access through provider education, NYMAC’s website provides resources for 
healthcare providers, include summary documents outlining guidelines and recommendations for 
making genetics referrals.77  
There is currently limited information available about the success of efforts to connect 
medically underserved populations with relevant genetic services. Development of a genetic 
services referral phone line resource in the NYMAC region has the potential to increase awareness 
of and connect populations in need with relevant genetic services. Implementation of this phone 
line and evaluation of the utilization can provide information for quality improvement of this effort 
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within the NYMAC Region and similar future efforts aimed at increasing access to genetic 
services. Evaluation of phone line implementation can also provide insight as to types of resources 
which may or may not effectively reach medically underserved populations or healthcare 
providers, and how to adapt or develop interventions and resources for future use.  
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3.0 Manuscript 
3.1 Background 
3.1.1  Access to Healthcare and Genetic Services 
In a current healthcare climate where disparities and barriers to relevant healthcare services 
exist,5,6 a public health focus on strategies for increasing access to healthcare services for 
underserved populations is crucial. According to the U.S. Health Resources & Services 
Administration (HRSA), Medically Underserved Areas and Populations (MUA/Ps) are designated 
as areas or populations which lack adequate primary care services, with high percentages of the 
population aged 65 or older and high levels of poverty and infant mortality.4 This type of 
designation may correlate with National Rural Health Association (NRHA) findings that 
individuals in rural areas have decreased access to physicians, lower socioeconomic status, and on 
average, a larger elderly population,7 suggesting that a focus on increasing access should be given 
to these populations.  
Workforce shortages in healthcare related fields, in part, may contribute to barriers to 
access of healthcare services. Assessments of rural healthcare systems show the extent of such 
shortages, with 100% of rural hospital CEOS in the New England to Virginia region citing an 
overall physician shortage, with the majority citing shortages in at least two primary care 
specialties.8 However, workforce shortages are not limited to primary care. A 2018 workforce 
study of the genetic counseling profession has suggested that the shortage of genetic counselors 
(GCs) working in direct patient care may not resolve until the year 2030,9 with a 2003 workforce 
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analysis of clinical geneticists suggesting an insufficient supply of medical geneticists in 17 states 
across the U.S, with some states averaging 2.0 or less geneticist per 1 million people.10  In addition 
to shortages of GCs and other genetics professionals, multiple studies have found that additional 
barriers exist regarding access to genetic services for underserved and rural populations, such as 
racial and ethnic disparities12,13, logistical barriers (i.e. distance to genetics service location, 
referral or insurance coordination, etc.) and knowledge barriers (i.e. lack of awareness of 
availability of genetic services, lack of knowledge of what constitutes an appropriate referral, 
etc.).1,2,14–18  
Initial efforts to address workforce shortages and barriers in hopes of increasing access to 
genetic services involve adoption of alternative services delivery models, including group genetic 
counseling, telegenetics, and genetic counseling assistants or extenders.3,19–21 Telegenetics 
services have been found to be successful in reaching individuals who may not have otherwise 
been able to access genetic services, and telegenetics program adopters have reported increases in 
the number of patients served, and from a wider geographic reach.22   
3.1.2  Genetics and Primary Care 
With an increasing demand for genetic services and a shortage of genetics healthcare 
providers, integration of genetics into primary care is becoming increasingly prevalent.27 As 
healthcare providers who are responsible for providing and coordinating a variety of healthcare 
services for their patients, primary care providers (PCPs) play a role in facilitating relevant genetic 
care for their patients.24,27 Prior studies have surveyed or interviewed PCPs regarding their 
perception of genetic services and the role of genetics in primary care. PCPs have acknowledged 
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their responsibility to identify patients in need of genetic services, and place appropriate referrals, 
while also raising concerns about their own genetics knowledge.27,35,40  
In regard to medical education for PCPs in training, genetics is being increasingly included 
in curriculum development; however, no standardized genetics coursework is currently being 
implemented across all institutions.28,31 Professional groups including The National Coalition for 
Health Professional Education in Genetics (NCHPEG) and Association of Professors of Human 
and Medical Genetics (APHMG) have worked to establish competencies that can be used to 
address potential gaps in healthcare provider genetics education; however, PCPs and other 
healthcare providers must recognize the potential limitations of their knowledge, while having and 
understanding of the implications of genetic assessment and knowing when and how to refer 
patients appropriately to genetic services.33,34 Assessments of genetics integration in medical 
education suggest that PCPs identify weaknesses in their genetics education, citing difficulties 
finding relevance of genetics in daily practice, and associating genetics with rare or very specific 
health conditions.36,37  
PCPs often agree that their role is to assist in coordinating referrals to genetics; however, 
in addition to lack of knowledge, PCPs raise multiple concerns about integrating genetics into 
primary care practice, including being unable to keep up with current developments in the field; 
not having enough knowledge about available genetic testing options and their utility and/or 
implications for patient management; inability to recognize patients who may benefit from a 
genetics referral; and lack of relationships or awareness of relevant genetics healthcare providers 
in the area in which they practice. 40–42,44 While identifying PCP concerns and perceptions of 
genetics and associated barriers to access, multiple studies have also prompted suggestions from 
PCPs about resources which would make for a smoother integration of genetics into primary care 
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practice, including referral and risk assessment guidelines, information specific to genetic testing 
and associated benefits, a go-to individual or resource available for questions related to genetics 
care for patients, and a telephone hotline to provider information.35,36,40,41 
3.1.3  Telephone Hotlines 
Telephone call centers or hotlines have long been used as resources to connect individuals 
with services in a variety of settings. Hotlines managed by groups such as the Rape, Abuse and 
Incest National Network (RAINN) and the Department of Veterans Affairs have been 
implemented with the goal of providing support and advice to individuals who may lack nearby 
in-person services or may be part of a demographic less likely to pursue in-persons services.48,49 
Hotlines have been designed and implemented to target individuals, patients, consumers, 
as well as healthcare providers. Following implementation of hotline services, evaluation of 
utilization, limitations, and areas for improvement can be fundamental to ensuring that such 
telephone lines are meeting their goals and providing intended services or resources. Hotline 
evaluation projects can be important in recognizing the need for modifications to effectively reach 
target groups, with long-term and follow-up utilization studies providing valuable information 
about strategies which may or may not effectively increase hotline utilization by a target 
demographic.51–53 While efforts to provide increased access and resources to target demographics 
may not be as effective as intended, lessons can be learned from these types of studies. For 
example, one study of an under-utilized provider resource hotline in Africa was able to evaluate 
call data and survey those who did or did not utilize their phone line to identify barriers, limitations, 
and future expansion opportunities.50  
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3.1.4  Regional Genetics Networks and NYMAC 
As part of efforts to improve the health of children and families in the United States by 
connecting genetics, newborn screening, and public health, the Maternal and Child Health Bureau 
(MCHB) of HRSA, Genetic Services Branch (GSB) provides funding for a National Coordinating 
Center (NCC) and seven Regional Genetics Networks (RGNs).57,58 In partnership with the 
American College of Medical Genetics and Genomics (ACMG), the NCC and RGNs 
collaboratively develop educational resources, and work towards improving access to genetics 
services for MUA/Ps.63 In particular, a 2015 needs assessment conducted jointly by ACMG and 
the NCC identified barriers associated with access to genetics services, including distance, lack of 
available genetics service providers, and lack of awareness.11 
One of the seven national RGNs, the New York-Mid-Atlantic Consortium (NYMAC) 
Regional Genetics Network serves Delaware, District of Columbia, Maryland, New Jersey, New 
York, Pennsylvania, Virginia, and West Virginia.68 NYMAC focuses on a variety of projects, with 
a unifying goal of improving access to genetic services, in particular for MUA/Ps in the region.70 
In order to address previously identified barriers to genetic services, NYMAC implemented the 
Genetic Services Referral Phone Line in 2019. Targeted towards both individuals and healthcare 
providers, trained NYMAC staff utilize a regional clinical services directory to provide phone line 
callers with referral and contact information for genetic services near the caller’s location, 
including telemedicine sites.74 
To date, phone line utilization has been much less than anticipated, despite efforts to 
increase awareness of the phone line through marketing campaigns. With limited information of 
the success of prior efforts to increase access to genetic services for MUA/Ps, this assessment 
serves to detail the implementation process for the NYMAC Genetic Services Referral Phone Line 
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and evaluate phone line utilization, as well as strengths and limitations of implementation efforts, 
through evaluation of website and call data, marketing campaign reach, and healthcare provider 
perceptions of barriers to genetic services. This quality improvement assessment will provide 
baseline information regarding the effectiveness of a hotline aimed at assisting callers with locating 
appropriate genetic services and act as a guide for future NYMAC efforts to increase access to 
genetic services for MUA/Ps, and potentially future efforts of other RGNs.    
3.1.5  NYMAC Genetic Services Referral Phone Line Implementation 
3.1.5.1 Needs Assessment 
Following a regional needs assessment, NYMAC identified areas in which support 
resources could be integrated in order to address barriers to access to genetic services. Areas which 
could be addressed included increased awareness and resources for PCPs, increased education 
regarding available telegenetics services and assistance in implementation of telegenetics services 
across the region, and increased outreach to inform and connect individuals residing in the region 
with available genetic services (NYMAC, unpublished data, 2015). In order to increase access to 
genetic services for individuals within the region, particularly MUA/Ps, NYMAC developed and 
implemented the Genetic Services Referral Phone Line in 2018. The phone line was designed to 
be used as resource for both patients and healthcare providers, with established goals of assisting 
callers in identifying relevant genetic services or family-led organizations in their area, increasing 
the amount of patients from MUA/Ps who are appropriately referred to genetic services, and 
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improving overall access to genetic services in the region. The NYMAC Genetic Services Referral 
Phone Line implementation process and goals are outlined in Figure 2.  
 
Figure 2. NYMAC Phone Line Implementation Logic Model 
3.1.5.2 Clinical Genetic Services Directory 
NYMAC, under the coordination of the NCC and ACMG, maintains a regional clinical 
genetic services directory. Originally maintained internally via Google Maps, the directory was 
manually updated by staff members when new clinic information was made available to NYAMC. 
Upon the announcement that ACMG and the NCC would be working with the RGNs to update a 
national clinical genetics service directory hosted on the ACMG website, NYMAC staff contacted 
genetic services locations in the region via telephone and/or email in order to obtain updates to 
current directory listings. These update efforts were made in order to compile the most up to date 
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clinical genetic service location information in the internal directory, which would then be used 
by ACMG and the NCC to update the online directory.75 
When phone line implementation began in August 2018, an email announcement was sent 
to a current NYMAC regional email list, including healthcare providers, family-led organizations, 
and other partners, and post cards were sent to healthcare provider offices in the NYMAC region. 
This advertising served a dual purpose, introducing the phone line to individuals and healthcare 
providers in the region, and also leading individuals affiliated with genetic services locations to 
contact NYMAC in order to have their clinic added to the directory or to ensure their clinic 
directory listing was up to date.  
In December 2019, the NYMAC regional clinical services directory began integration into 
a national clinical genetic services directory publicly available via the ACMG website. Visitors to 
the ACMG directory can search for genetic services nationwide using location-based search fields 
or clinic name and an interactive map. This directory was not used for locating genetic services 
during phone line implementation; however, following completion and official launch of the 
national directory, the online ACMG directory, rather than the NYMAC regional directory, will 
be used to locate relevant clinical genetics services for phone line callers. In addition to search 
functionality, the ACMG directory website page includes online forms which clinic locations can 
fill out to submit a new clinic for inclusion into the directory. Functionality is being developed so 
that clinics can also submit edits to their current directory listing on their own. Figure 3 illustrates 
a timeline of phone line implementation activities, including clinical service directory updates, as 
well as efforts to increase phone line awareness, which will be further outlined in subsequent 
sections.  
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Figure 3. Phone Line Implementation Timeline 
3.1.5.3 Phone Line Staffing 
The phone line is housed within Verizon inContact, a cloud-based virtual contact center 
which allows for the phone line to be staffed remotely. The phone line was staffed part-time by 
Master’s in Genetic Counseling graduate student workers from the University of Pittsburgh from 
August 2018 through May 2020. Bi-weekly meetings were held with student workers and members 
of the NYMAC leadership team to discuss the phone line, utilization, and staff concerns. Standard 
hours of operation were initiated in January 2019 and published and updated regularly on the 
NYMAC phone line website. The phone line was staffed two to three days per week, primarily 
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during business hours (Monday through Friday, 8:00am-5:00pm), with occasional availability 
during early mornings, evenings, and weekends. Phone line staff were available to answer calls 
between 8-19 hours per week. During the hours that a staff member was unavailable to answer 
calls, a voicemail system was in place, allowing callers to leave a message.  
3.1.5.4 Phone Line Website 
The phone line was managed by NYMAC and coordinated through the Wadsworth Center 
at the New York State Department of Health (NYSDOH). The NYMAC RGN website is housed 
with the NYSDOH website, and a phone line specific webpage with URL redirect 
(wadsworth.org/nymac/referral) was added to the site in September 2018. The phone line web page 
included the phone line contact phone number and hours of operation, as well as a brief description 
of the purpose of the phone line, what to expect during the call, and why genetic services may be 
helpful to some individuals. A NYMAC email address for general questions was also published 
on the website and phone line webpage. In February 2019, a “contact us” form was added to the 
phone line webpage to allow individuals to contact phone line staff with questions via email 
directly through the website.  
3.1.5.5 Phone Line Protocol 
When a caller contacted the NYMAC Genetic Services Referral Phone Line, they were 
prompted to provide their zip code within an automated phone tree as this information was needed 
to find the genetic services closest to them and was requested to be collected by HRSA. No 
additional identifiers or medical information were recorded. After providing this initial 
information, the caller was connected with an available phone line staff member during staffed 
hours of operation. If the caller was contacting the phone line to locate genetic services, staff used 
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the caller’s zip code to locate relevant genetics service location(s) nearest to the caller, or 
appropriate telegenetics resources, via the regional NYMAC Clinical Services Directory and map.  
Staff provided callers with referral information for relevant genetic service location(s) 
based on their needs by providing contact information for the relevant location. Staff were also 
able to provide information on appointment wait times and accepted Medicaid insurance plans. 
Inquiries were also accepted via email. Individuals who contacted phone line staff via the online 
“contact us” form were able to provide their contact information, zip code, and questions or 
concerns via this contact method, and phone line staff responded with requested information by 
either phone or email, as appropriate.  
Of note, the phone line did not provide formal “referrals” to genetic services, in which care 
would be coordinated and an appointment would be facilitated for a caller; rather, the phone line 
provided contact information for relevant genetics services based on location and needs for each 
caller. Following receipt of this information from NYMAC, it was the caller’s responsibility to 
contact a genetic services location or support resource to facilitate services and necessary formal 
referrals from their healthcare provider. For consistency with phone line nomenclature, throughout 
this document, usage of the word “referral” in the context of assisting a phone line caller refers to 
“information about genetic services nearest to them that met their stated needs,” rather than a 
formal referral to a genetic service location.   
The staff were trained to locate and provide information regarding relevant genetics 
services in the NYMAC region and were not trained to answer medical questions or provide 
advice. All callers with medical questions or questions related to specific genetic conditions were 
transferred or referred to GARD. Callers looking for additional support services were transferred 
or referred to the relevant family-led organization for their state. In cases where callers contacted 
  43 
the phone line outside of staffed hours of operation, they were prompted to leave a voicemail 
message, and asked to provide their name and contact phone number so that a staff member could 
return their call. This information was not recorded in any way and was only used for the purposes 
of returning the initial phone call. A phone line staff member addressed all voicemail messages or 
email inquiries within 48 business hours.  
3.1.5.6 Marketing Campaigns 
Following initial emails and postcards sent in 2018, NYMAC used an external marketing 
consultant, OpAD Media, to launch multiple advertising campaigns to increase awareness of the 
Genetic Services Referral Phone Line amongst individuals residing within HRSA-designated 
MUA/Ps. Based on prior NYMAC efforts to engage with PCPs in the state of Maryland, Maryland 
was selected as a pilot state for a digital marketing campaign. On January 7, 2019, online digital 
advertisements (Appendix B) were launched in nine targeted counties the state of Maryland 
designated as a MUA/P by HRSA. The marketing campaign was expanded to two counties in the 
state of Delaware designated as MUA/Ps on March 1, 2019 (Appendix C). The Maryland and 
Delaware marketing campaigns were active through May 31, 2019. Individuals from these targeted 
areas who interacted with advertisements on social media websites (Facebook and Instagram) were 
prompted to call the phone line or linked directly to the NYMAC Genetic Services Referral Phone 
line webpage. Location-targeted online webpage banner advertisements, or advertisements 
embedded within webpage margins which allow users to click the advertisement to visit a website, 
and search engine advertisements (Google and Bing), in which the phone line website appeared as 
a sponsored search result, were also utilized.  
Call trends through 2019 suggested that those who contacted NYMAC via the phone line 
or email were primarily from the state of New York, despite no active marketing in that state. It 
  44 
was postulated that because the NYMAC website is housed on the NYSDOH website, the service 
was more likely to gain attention of individuals in New York. Because of this, an additional digital 
marketing campaign targeting six counties in the state of New York was launched on January 6, 
2020, with an end date of March 29, 2020.  
Between May 31, 2019 and June 10, 2019, an email marketing campaign targeted towards 
healthcare providers (Appendix D) was launched in order to increase awareness and of the phone 
line as a referral resource for healthcare providers. During this time, an email blast was sent three 
times to healthcare providers practicing in Pediatrics, Internal Medicine, Obstetrics/Gynecology, 
and Oncology via Medical Marketing Services, Inc., an email marketing service to healthcare 
professionals. 
In order to raise awareness about the Genetic Services Referral Phone Line, NYMAC made 
a brief informational presentation at a regional Family Voices meeting in June 2019. NYMAC also 
contributed an article to the August 2019 issue of Exceptional Parent magazine in order to 
highlight the phone line and its services.  
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3.2 Methods 
3.2.1  Ethical Considerations 
Per the Institutional Review Board of the University of Pittsburgh, this project does not 
meet the formal definition of research (IRB#1807003- Appendix A). The Institutional Review 
Board was contacted as several time points during the project and indicated that approval was not 
required for any aspect of this project. 
3.2.2  Call Data Collection & Analysis 
Data was collected during and after all incoming and outgoing phone line calls (Table 1). 
Actively collected data included caller demographics and information about services sought and 
was collected from all callers who were willing to provide the information in order to identify the 
most appropriate genetic services. Passively collected data was collected from callers if it was 
reported during the call; however, callers were not required to provide this information and staff 
did not probe for this information. Following a conversation with a caller, call outcome data was 
also tracked.  
 
 
 
 
 
  46 
Table 1. Phone Line Data Collection Points 
 Data Field Description 
Actively 
Collected 
Information 
Zip code 
Entered in by caller prior to being connected with phone 
line staff member 
Caller type 
Individual 
Provider (Geneticist, PCP, Pediatrician, OB/GYN, Public 
Health Professional) 
Other 
Type of services sought 
Prenatal Genetics 
Pediatric Genetics 
Adult Genetics 
Cancer Genetics 
General Genetics 
Genetic Testing 
Other 
Age of individual needing 
services 
Under 18 
18-29 
30-39 
40-49 
50-59 
60+ 
How caller found out about 
phone line 
Google 
Facebook 
Physician(s) 
NYMAC website 
Advertisement 
Other 
Passively 
Collected 
Information 
Purpose of services sought 
Diagnostic 
Post-Diagnostic counseling 
Family History 
Other 
Insurance type 
Public 
Private 
Uninsured 
Call 
Outcome 
Information 
Clinic(s) referred to Documentation of which clinic(s) caller was referred to 
Type of service(s) referred 
to 
Genetics (In-person, Telegenetics, Telegenetics 
Navigation, GARD, Support Group) 
Not genetics related 
Other 
 
3.2.2.1 Call Volume & Phone Line Utilization 
NYMAC website analytics were obtained starting from phone line implementation on 
August 2, 2018 and tracked through February 18, 2020. Phone line contact history and data reports 
were downloaded directly from the phone line call center online platform, Verizon inContact. Calls 
that were identified as test calls, NYMAC staff calls, or outgoing staff calls for non-referral related 
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reasons were removed from data analysis. Remaining calls were coded based on if they were 
handled, pre-queue, or voicemails. Incoming or outbound calls in which a caller spoke with a 
NYMAC staff member and potentially received information about a genetic service location 
and/or support resource were considered “handled.” All incoming calls were logged within the call 
center online platform; however, if a caller hung up, or did not navigate through the automated 
phone tree, and was never connected to a phone line staff member or voicemail system, the call 
was considered “pre-queue.” Calls which resulted in a voicemail message were assessed 
individually, to determine if the call was ultimately handled. Incoming email inquiries were also 
assessed individually to determine the nature of the inquiry and if the email inquiry was ultimately 
handled. Based on the availability of caller zip code data, calls and emails were coded based on 
whether the caller-provided zip code was designated as a MUA/P by HRSA. 
3.2.3  Marketing Campaigns 
Following the digital marketing campaign in Maryland and Delaware, and at the mid-point 
of the New York State marketing campaign, data detailing marketing reach were obtained directly 
from OpAD Media. Similar data were obtained from Medical Marketing Services, Inc. following 
the healthcare provider email campaign. Data on marketing impressions, emails delivered, and 
associated NYMAC phone line calls and webpage clicks were analyzed to determine potential 
trends in phone line utilization. 
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3.2.4  Healthcare Provider Perspectives  
Invitations to participate in telephone interviews (Appendix E) were sent to 12 PCPs via 
email. Three were PCPs practicing within the NYMAC region who had previous involvement with 
NYMAC and nine were PCPs practicing in the Pittsburgh, Pennsylvania area. Interested PCPs 
contacted the author via email and were informed about NYMAC, the phone line, and interview 
purposes. Formal consent was not required per the Institutional Review Board at the University of 
Pittsburgh because this was considered to be a quality improvement project. PCPs were made 
aware that agreement to participate in the interview implied consent, with the option to decline to 
answer questions or end the interview at any time. 
A semi-structured interview guide (Appendix F) was developed to assess PCPs’ 
experiences with referring patients to genetics, barriers they or their patients may have experienced 
related to a genetic referrals, and their perceptions of the NYMAC phone line and its 
implementation process. Interviews were conducted and recorded using Skype for Business and 
subsequently transcribed verbatim and de-identified by the author. Interview times ranged from 
approximately 13 minutes to 23 minutes., with an average length of approximately 18 minutes. 
Thematic analysis was used to analyze transcribed interviews, utilizing an inductive coding 
method, in which themes arose directly from the interview data, rather than coding to fit within a 
predetermined codebook.78 Interviews were coded independently in Microsoft Word, with all 
resulting codes being combined and analyzed together. Analysis was completed at the semantic 
level, focusing on the explicit statements and meanings present in the interview data.78  
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3.3 Results 
3.3.1  Website Traffic 
As summarized in Table 2 and Appendix G, NYMAC website analytics were obtained 
starting from the date of the phone line implementation and tracked during periods of both active 
marketing campaigns and no marketing campaigns. Analytics from August 1, 2018 through 
January 6, 2019 (159 days), prior to any phone line marketing campaigns, showed 1,896 views 
across the entire NYMAC website. The NYMAC phone line specific webpage received a total of 
232 views (12.2%), with 83.6% of those being unique views (n=194), an average of 1.2 unique 
views per day. Following the initial marketing campaign, analytics from January 7, 2019 through 
May 31, 2019 (145 days) showed 24,123 views across the entire NYMAC website, with the phone 
line specific webpage receiving a total of 20,638 views (85.6%), with 93.2% of these being unique 
views (n= 19,233), for an average of 132.6 unique views per day. From June 1, 2019 through 
January 5, 2020 (219 days), a period during which no marketing campaigns were active, there were 
2,427 views across the entire NYMAC website. There were a total of 368 (15.16%) views of the 
phone line specific webpage, 85.6% of which were unique views (n=315), with an average of 1.4 
unique views per day. Analytics from January 6, 2020 through February 18, 2020 (44 days), 
approximately midway through an active marketing campaign, showed 29,807 total NYMAC 
website views, and 23,752 phone line web page views (79.7%), 22,069 of which were unique 
views (93.0%). During this time, the phone line specific webpage received 501.6 unique views per 
day, on average. All additional website activity can be attributed to other areas of the NYMAC 
website unrelated to the phone line.  
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Table 2. NYMAC Website Analytics 
Date Range 
Active 
Marketing 
Campaign? 
NYMAC 
Website 
Views 
NYMAC 
Website 
Homepage 
Views 
Phone Line 
Webpage 
Views 
Unique Phone 
Line Webpage 
Views 
Average 
Unique 
Webpage 
Views Per Day 
n n (%) n (%) n (%) n 
08/01/2018 – 01/06/2019 No 1,896 540 (28.5) 232 (12.2) 194 (83.6) 1.2 
01/07/2019 – 05/31/2019 Yes 24,123 685 (2.8) 20,638 (85.6) 19,233 (93.2) 132.6 
06/01/2019 – 01/05/2020 No 2,427 703 (28.97) 368 (15.16) 315 (85.6) 1.4 
01/06/2020 – 02/18/2020 Yes 29,807 1,510 (5.1) 23,752 (79.7) 22,069 (92.9) 501.6 
 
3.3.2  Call Volume & Email Contact 
Between August 2, 2018 and February 18, 2020, the NYMAC Genetic Services Referral 
Phone Line received 67 calls from 51 unique callers. Of the 67 calls, 8 (11.9%) callers spoke with 
a phone line staff member. Voicemails were left by 9 callers, and the remaining 50 calls (74.6%) 
were classified as “Pre-Queue,” meaning the callers did not navigate through the phone tree and 
were not connected with a staff member or voicemail system. 73.1% (n=49) of calls were received 
during an active marketing campaign, with 26.9% (n=18) calls received outside of active 
marketing campaigns. More calls were made from mobile phones (n=38) than were made from 
landlines (n=29). NYMAC also received 6 inquires via email. The trends in inquiries are illustrated 
in Figure 4. 
NYMAC staff members addressed inquiries from 16 people during this time period (Table 
3). 100% of inquiries via phone or email were received during an active phone line marketing 
campaign. Of note, one caller indicated that she/he had received an email from NYMAC that 
prompted the call, but it was unclear if this was an email sent during the provider-targeted 
marketing campaign. 75% (n=12) of inquiries were made via phone, with two callers also 
contacting NYMAC via email in addition to their telephone call. The majority of inquiries (81.3%) 
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were made by individuals, or consumers/potential patients. Of those who contacted NYMAC, eight 
(50%) were referred to an in-person genetics or telegenetics service and one individual (6.3%) was 
referred to a relevant support resource. The most common reasons that the phone line was utilized 
included family history (18.8%), direct-to-consumer/ancestry testing information (18.8%), post-
diagnostic counseling (12.5%), and diagnostic services (12.5%). 
 
Figure 4. Total NYMAC Inquiries and Inquiries Handled 
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Table 3. NYMAC Inquiries Handled 
Contact 
Type 
MUA/P? 
Caller 
Type 
Type of 
Service 
Sought 
Patient 
Age 
How Caller 
Found Phone 
Line 
Purpose of 
Service 
Sought 
Type of 
Service 
Referred to 
Call During 
Marketing 
Campaign? 
Incoming 
Call 
Yes 
Individual 
 
Pediatric 
Genetics 
N/A 
Other- Family 
Group 
Post-
diagnostic 
Counseling 
N/A Yes- MD 
Email No Individual 
Adult 
Genetics 
30-39 N/A Diagnostic 
Genetics- In-
Person 
Yes- MD 
Incoming 
Call 
N/A Other Other N/A N/A N/A N/A Yes- MD 
Incoming 
Call 
N/A Individual Other N/A N/A Other- DTC N/A Yes- MD/DE 
Incoming 
Call 
Yes Individual 
Pediatric 
Genetics 
Under 
18 
Other- Family 
Group 
Family 
History 
Genetics- In-
Person 
Yes- MD/DE 
Email Yes Individual N/A N/A N/A N/A N/A Yes- MD/DE 
Incoming 
Call 
Yes Individual Other N/A N/A Other- DTC N/A Yes- MD/DE 
Outgoing 
Call 
(Voicemail 
follow-up) 
No Individual 
Pediatric 
Genetics 
Under 
18 
N/A 
Post-
diagnostic 
Counseling 
Genetics- In-
Person; 
Telegenetics 
Yes- MD/DE 
Incoming 
Call 
Yes Individual Other N/A N/A Other- DTC N/A Yes- MD/DE 
Email Yes Individual N/A N/A N/A N/A N/A Yes- MD/DE 
Incoming 
Call 
Yes Individual 
Adult 
Genetics 
60+ Email 
Family 
History 
Genetics- 
Telegenetics 
Yes* 
Incoming 
Call 
No Individual 
Adult 
Genetics 
N/A Advertisement 
Family 
History 
Genetics- In-
Person; 
Telegenetics 
Yes- Provider 
Email 
Email 
and 
Outgoing 
Call 
(Voicemail 
follow-up) 
No 
Other – 
Specialty 
Provider 
General 
Genetics 
40-49 Google N/A 
Genetics- In-
Person 
Yes- NY 
Email 
and 
Outgoing 
Call 
(Voicemail 
follow-up) 
No Individual 
Adult 
Genetics 
40-49 Google N/A 
Genetics- In-
Person 
Yes- NY 
Email Yes N/A 
Genetic 
Testing 
18-29 N/A N/A 
Genetics- 
Support 
Group 
Yes- NY 
Outgoing 
Call 
(Voicemail 
follow-up) 
No Individual 
Adult 
Genetics 
40-49 Google Diagnostic 
Genetics- In-
Person 
Yes- NY 
Abbreviations: N/A- Not available; DTC- Direct-to-consumer genetic testing; MD- Maryland; DE- Delaware; NY- New York 
*caller reported receiving email from NYMAC 
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Calls were received during all seven days of the week, with 74.6% of calls received on 
Monday, Tuesday, or Thursday (n=50), which is consistent with the most common days during 
which staffed phone line hours were available. Approximately one quarter of calls (25.4%) were 
received on Sunday, Wednesday, Friday, or Saturday (n=17). Calls were received during a variety 
of times, with a preference for afternoon (after 12:00pm). 41.8% of calls (n=28) were received 
during morning hours (12:00am – 11:59am), with three calls received prior to 8:00am. 58.2% of 
calls (n=39) were received during afternoon hours (12:00pm – 11:59pm), with 11 calls received 
after 5:00pm (Figure 5). Of the 67 total calls received, 29.9% (n=20) were received during phone 
line hours of operation, with 56.7% (n=38) of calls received outside of hours of operation. Of note, 
13.4% (n=9) of calls were received prior to regular phone line hours of operation being established.  
Figure 5. Call Data by Day of the Week and Time of Day 
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3.3.3  Marketing Campaigns 
Between January 7, 2019 and May 31, 2019, social media advertisements in target MUA/Ps 
in Maryland and Delaware, which prompted those interacting with the advertisement to call the 
NYMAC Genetic Services Referral Phone Line (also known as “click to call” advertisements), 
were displayed 1,934,891 times, also called impressions, across Facebook and Instagram, resulting 
in a reach of 253,400 unique viewers. Social media advertisements that linked to the NYMAC 
phone line website delivered 5,450,279 impressions and resulted in 27,741 website clicks. Banner 
advertisements on various websites resulted in 3,967,036 impressions and 5,524 website clicks. 
Search engine advertisements resulted in 21,165 impressions delivered and 608 website clicks. 
Between May 31, 2019 and June 10, 2019 provider-targeted marketing emails were sent 
out three times and reached over 48,000 PCPs (Table 4). During the first email send-out, 95.9% 
of emails were successfully delivered to 48,594 PCPs. Delivered messages resulted in 3,334 
(6.7%) unique individuals opening the email, generating 62 unique clicks to the NYMAC phone 
line website. The second and third email send-outs were successfully delivered to 99.9% 
(n=48,458) and 99.7% (n=44,792) of PCPs, respectively. The second email send-out resulted in 
3,387 (7.0%) unique opens and 52 unique website clicks. The third email send-out resulted in 
1,523 (3.4%) unique opens and 17 unique website clicks. In total, the provider marketing campaign 
generated 131 unique clicks to the NYMAC phone line website, which account for approximately 
41.6% (131 of 315 total) unique phone line website views during this time period. 
 
 
  55 
Table 4.  Provider Marketing Email Reach 
Send-out 
Number of 
Emails Sent 
Delivered Emails 
 
n (%) 
Unique Opens 
 
n (%) 
Unique Website Clicks 
 
n (%) 
1 50,679 48,594 (95.9) 3,334 (6.7) 62 (0.13) 
2 48,532 48,458 (99.9) 3,387 (7.0) 52 (0.11) 
3 44,908 44,792 (99.7) 1,523 (3.4) 17 (0.04) 
 
Mid-marketing campaign data from January 6, 2020 to January 28, 2020 from the ongoing 
marketing campaign (January 6, 2020 through March 29, 2020) in New York State showed a total 
of 1,015,871 impressions across social media and internet search engines. Facebook and Instagram 
advertisements delivered 992,832 impressions and generated 4,655 website clicks. Google and 
Bing search advertisements delivered 23,039 impressions and generated 639 website clicks. 
Impressions from both online marketing campaigns are summarized in Table 5.  
Table 5. Marketing Impressions and Website Activity 
Campaign Date Range 
Social Media 
(Facebook, Instagram) 
Internet Search (Google, Bing) Web Banner 
Impressions Website Clicks 
(% impressions) 
Impressions Website Clicks 
(% impressions) 
Impressions Website Clicks 
(% impressions) 
01/07/2019 – 05/31/2019 
(Maryland, Delaware) 
5,450,279 
27,741 
(0.51) 
21,165 
608 
(2.87) 
3,967,036 
5,524 
(0.14) 
01/06/2020 – 03/29/2020 
(New York) 
992,832 
4,655 
(0.47) 
23,039 
639 
(2.77) 
N/A N/A 
Totals 6,443,111 
32,396 
(0.50) 
44,204 
1,247 
(2.82) 
3,967,036 
5,524 
(0.14) 
 
3.3.4  Provider Interviews 
Emailed interview invitations had a 33.3% response rate (n=4), and four providers 
scheduled and completed telephone interviews. One provider had previous experience working 
with NYMAC (Provider A), and three providers were from the Pittsburgh, Pennsylvania area and 
were not familiar with NYMAC or the Genetic Services Referral Phone Line (Providers B-D). All 
four providers identified themselves as family medicine physicians (PCPs) and described the areas 
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they practice in and at least a subset of the patients they serve as medically underserved and/or of 
low socioeconomic status, with one provider noting practicing in a rural area and one also 
describing their practice area as urban. Two providers reported serving a large population of 
African American patients, and two providers reported a large part of their patient population 
having health insurance coverage through Medicaid. 
All providers interviewed had had some experience referring a patient for genetic services, 
with the most common indications being prenatal genetic screening and cancer genetics. In 
discussing the NYMAC phone line, implementation process, and additional barriers to genetic 
services, common themes and subthemes were identified and grouped into four themes of interest 
based on the semi-structured interview questions: patient-related barriers to genetic services, 
provider-related barriers to genetic services, perceptions of the NYMAC phone line and 
implementation, and additional patient or provider resource suggestions. Thematic analysis is 
summarized in Table 6.  
Table 6. Common Themes in Provdier Interviews 
Themes Subthemes 
Patient-Related Barriers 
Appointment wait times 
Genetics workforce 
Patient perceptions 
Provider-Related Barriers 
Training/Education 
Awareness 
NYMAC Phone Line 
Utilization 
Existing resources 
Resource Suggestions 
Telemedicine/Telegenetics 
Electronic health record (EHR) integration 
 
3.3.4.1 Patient-Related Barriers to Genetic Services 
When asked about perceived barriers to patients accessing genetic services, two PCPs 
interviewed identified appointment wait times as an area of concern. One provider stated: 
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Well access is, um, a problem, delay in having people seen. More for the 
adult…um, the adults…there’s a time delay and people are getting, if they want 
evaluation for cancer genetics, they’re often, um, very much in a hurry to do so. 
(Provider B) 
 
Another provider shared: 
Um, sometimes the amount of time that it takes for the patient to get in. Um, that’s 
probably the biggest barrier I’d guess. Especially with pregnancy because 
whenever we’re trying to do first trimester screening trying it has to be during 
certain period of time, and if a patient is coming to see me kind of toward the end 
of her first trimester, then we don’t have too much time for that to happen. 
(Provider C) 
 
The workforce shortage of genetics professionals was also a perceived patient barrier for 
two PCPs, with one provider sharing: 
I think we’re all conscious of overuse or misuse of our specialists’ time, and 
perhaps that’s a concern. (Provider B) 
 
The other provider related the genetics workforce shortage to their experience with individuals 
without genetics expertise providing genetics services: 
The other barrier that’s come to…come into place really recently is a lot of 
unqualified folks that are offering genetic services shouldn’t be doing it. Um, for 
instance, our breast care center, um, has set up a cancer genetics program of 
sorts that’s really managed by a radiologist, who as far as I can tell really doesn’t 
have a background to do it…Um, and yeah they set up a cancer genetics 
evaluation program, um, again, not really with a medical geneticist or genetic 
counselors available. Um, so that’s the barrier at that end. I mean the barrier um 
with the heritable diseases is just availability of folks…um…nationwide. And 
there’s a relative shortage... (Provider A) 
 
Patient perception or knowledge of genetics and genetic services was also discussed as a 
barrier by two PCPs, with one provider sharing: 
And, um, but I think that the biggest problem that I bump into is really trying to 
get patients to understand kind of why we’re doing it, and why…the value, the 
potential value of it. Um, sometimes the hard part for me has been making that, 
closing that last loop, which is, I’ve thought, mentioned it to the patient but how 
to actually get the patient to the point of that expert. Um, so that’s, um, so I think 
that’s been kind of one of the challenges that I’ve had. (Provider B) 
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Another provider felt that examples of reasons for genetics referrals could be helpful information 
for patients to have if they are considering seeking genetic services. The provider stated: 
… I think a lot of times consumers in general aren’t sure if there’s somebody 
who would qualify for genetic testing or like kind of what sort of genetic 
disorders we would be looking at. Um, so I think a lot of people think of, um, 
you know, like pretty rare things, but I don’t think a lot of people think of like, 
oh breast cancer or you know, colon cancer, you know, I mean, any of the more 
common cancers that could really be a reason for referral for genetics… 
(Provider C) 
 
This provider also identified location of services, transportation, and cost as potential barriers for 
patients, though not barriers that the provider had personally experienced in their practice. Another 
provider felt that competing concerns may impact a patient’s likelihood to pursue a genetics 
consultation: 
…Maybe in the patients I see, I don’t really think of genetics as being a huge 
need for them. There’s a lot of socioeconomic factors that we work on all the 
time. And I…maybe I’m also underappreciating uh the role that genetics plays 
in their lives. (Provider D) 
3.3.4.2 Provider-Related Barriers to Genetic Services 
In addition to patient-specific barriers, all four PCPs interviewed identified healthcare 
provider understanding and/or knowledge as a barrier to patients receiving genetic services. PCPs 
noted that healthcare providers may be uncertain as to when a genetics referral is warranted. One 
PCP stated: 
I guess maybe a barrier that I’m imagining for the sake of your work is, um, 
perhaps providers don’t know exactly what’s appropriate. What is a really 
reasonable genetics referral? (Provider D) 
 
Another PCP felt that having examples of referrals could be helpful to providers, as well as 
patients, stating: 
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…I think a lot of genetics counseling is underutilized by a lot of providers. Um, 
I don’t think a lot of physicians know all of the information that we do have 
available now to be able to um, especially think about screening, moving 
forward based upon a patient’s history, so, that’s the same thing. Examples 
would probably be the easiest way to go about that. (Provider C) 
 
A third provider noted that an increased understanding would help them provide guidance for their 
patients, noting: 
…The more, the more I guess I, as a physician, understand what happens in 
those visits, the more I can tell them about what to expect… Um, and so I think 
part of that is it’s like a circle, because the more patients who go, then I get a 
report back and I talk to them, and I learn sort of what the expectations are and 
what I can tell patients… (Provider B) 
 
The fourth PCP discussed the importance of education and awareness about resources like the 
NYMAC phone line early on in a physician’s training, stating: 
I’m a big believer, um, when you’re trying to promote change um, in getting the, 
um, information and the process out to people that are in their training 
phase…Um, so anyway, so either they don’t have it burned in, so they’re 
particularly susceptible to something that be, that would help make their life 
easier. So if they knew about this, um, they would be more likely to use it than 
somebody who’s already got a way of doing things and something comes across 
their desk that there’s this new helpline and, you know, unless they’re really 
struggling, they’re not going to take advantage of it. Um, and um, I mean, so 
that’s one it makes their life easier, but the other thing is once you get folks in 
training hooked, then they’re quickly out of training and it’s a quick way to 
spread the word. (Provider A) 
3.3.4.3 NYMAC Phone Line 
All PCPs interviewed had generally positive perceptions of the NYMAC phone line. All 
PCPs expressed that the phone line seemed like a good resource, with one provider noting the 
phone line as a particularly helpful resource in the primary care setting: 
I like that it is via phone, I think that’s a really good idea. Um, I like that it is 
regional, I think that’s cool also. And then, past that, it sounds like it’s a ‘where 
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should I send this person?’ kind of resource, which in primary care we’re always 
looking for things like that. (Provider D) 
Two PCPs interviewed felt that the phone line was something that they would use themselves, 
contacting NYMAC to find genetic services for their patient(s); however, they would not 
recommend the NYMAC phone line as a resource for patient use. One PCP noted: 
For our, from the patients that I take care of, um, I probably wouldn’t do that. 
Their medical literacy and prowess in navigating the healthcare system is…I 
don’t know, I don’t know if that would go well. But I guess yeah, if I felt like 
someone was interested and had the resources to do that, yeah, I would 
absolutely do that. (Provider D) 
 
The other two PCPs felt that the phone line could be a useful resource for their patients, but they 
would not use the phone line as a resource for themselves, with one PCP stating: 
Um, I think from my standpoint, um, with being from the Pittsburgh area, I mean 
I usually refer to the genetics counselors through [health system], um, because 
that’s who I’m affiliated with. So, I think I can see the use of that, the utility of 
it if I was practicing in an area where I wasn’t sure where the resources 
were…Um, I think from a patient standpoint, it would probably be helpful, 
because then it kind of puts the onus on the patient to be able to you know, find 
somebody that is close to them, um, but I think being in an urban area makes it 
kind of difficult just because we sort of know where the resources are at this 
point, um, already. (Provider C) 
 
The second provider stated: 
I’m a firm believer of the whole medical home concept. I would probably do it...I 
mean, get the list of resources for them, and vet the resources myself…So I 
probably wouldn’t give the patient the web, the phone number, I would probably 
use it myself to try to find, um, what I was looking for. (Provider A) 
 
All four providers also noted that having existing relationships with genetics professionals 
or knowledge of resources in their area would impact their likelihood to use a resource like the 
NYMAC phone line. One provider noted: 
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…Ah, well first I feel fortunate because I practice where I practice. You know, 
I’m in Pittsburgh and you know, one of my colleagues is very much into genetics 
and so I know that there’s resources. (Provider B) 
A second provider mentioned the same colleague: 
Um, working with [physician], I feel extremely spoiled because I think me, and 
my colleagues, often just say to her directly “hey what do you think about this 
and where should we send this person?”…She’s kind of like the ideal resource. 
But I know that’s not, um, necessarily reproducible everywhere. (Provider D) 
3.3.4.4 Resource Suggestions 
In discussing the phone line implementation and potential utilization, all four PCPs had 
suggestions as to what type of resources would be potentially useful in helping them address 
barriers to genetic services for themselves and their patients. PCPs expressed that the most helpful 
resources are those that are easily accessible, with the most common suggestions relating to 
telemedicine/telegenetics as well as the electronic health record (EHR)/electronic medical record 
(EMR). Regarding the EHR, one provider noted: 
Um, as a provider, I can tell you we spend like all of our time with the EMR, and 
there’s like 10 million things to click on in a health record, and I don’t know if 
there’s a, if there’s a way that you guys could integrate your services into the 
health record, but I guess that would be…It would be at high risk of just getting 
lost in all of the other buttons to click on, but…perhaps docs prefer resources 
coming directly from, directly from Epic or from Cerner and they don’t always 
think about picking up the phone. (Provider D) 
Another provider explained an existing EHR tool which allows providers to refer patients for 
various health counseling services. Thinking about integration of a resource like the NYMAC 
phone line, the provider stated: 
Um, so, having something…not that it would have to be exactly like that, but I 
guess my point is that having something that was built into the EHR that may be 
easy for me to locate that counseling alternative has really increased the number 
of times I’ve used that service a lot. (Provider B) 
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In regard to telemedicine, one provider expressed that a telegenetics service resource may 
be more beneficial in increasing access to services, as opposed to a location service like the 
NYMAC phone line. When asked about their thoughts on the NYMAC phone line as it stands, the 
provider stated: 
I think, I wish that it was more, almost more telehealth based. So, um, I think it 
could be more helpful if there were more kind of phone consultation services 
that could be available for patients instead of just kind of connecting patients to 
services that are close to them. Um, I think that would be something that could 
be more beneficial than, um, just the actual ability to get the information about 
where to go for genetics. (Provider C) 
 
Another provider expressed interest in establishing telegenetics services at their practice location: 
We could, you know I could sort of serve as point person for that. I don’t feel 
capable of doing um you know full-service point of contact for most genetics 
things. But I also think with just a little bit of help, I probably could do some of 
this basic cancer genetics from my office…Um, but even for local, the local folks 
for genetics counselors with these fairly straightforward uh family histories and 
genograms, um, I could be guided in terms of any…you know, I could be guided 
in terms of basic information to gather when we have a conversation um and get 
any nuanced additional information um and then you know perhaps advice 
about the front-end testing. And then post-test have counseling, um you know, 
probably at this stage. Although, I’m getting better…I’m so involved in genetics, 
um, you know could be done again by telemedicine or face to face with a genetic 
counselor. (Provider A) 
 
This provider also suggested using a phone line for provider consultation services, rather than 
location-based services like the NYMAC phone line provides: 
…Um, not just to ask a simple question for a referral, but a phone line actually 
where I could do a…somebody sitting there, a genetic counselor or medical 
geneticist, probably a medical…a genetic counselor at the front end, that could 
sit there and you know I could schedule, we could schedule a time together for 
10-15 minutes to discuss a case, um, so that perhaps the, again, the patient 
wouldn’t have to go there, which is some, you know, it’s a distance. It’s an hour 
or better… (Provider A) 
  63 
3.4 Discussion 
3.4.1  Phone Line Utilization 
The goal of this project was to evaluate the implementation process and utilization of the 
NYMAC Genetic Services Referral Phone Line in order to identify potential strengths, limitations, 
and future directions for NYMAC to focus efforts in order to achieve their goal of increasing 
access to genetic services in the region. Analysis of the phone line utilization and marketing 
campaign reach were successfully completed as part of this evaluation project.  
Like other phone line utilization studies49, analytics from the NYMAC website showed 
that increased website activity correlated with active marketing campaigns which directed 
individuals to or linked individuals to the phone line webpage. The phone line webpage received 
substantially more views during active marketing campaigns, with an average of 132.6 unique 
views per day during the initial digital marketing campaign (Maryland and Delaware), in 
comparison to times where no marketing campaign was active, which had an average of 
approximately 1 view per day. Of note, data analysis was completed for the first half of the most 
recent digital marketing campaign (New York), and the unique phone line webpage views from 
January 6, 2020 through February 18, 2020 had already surpassed the total number of unique views 
during the prior marketing campaign (January 7, 2019 through May 31, 2019), with an average of 
501.6 unique views per day. These patterns in website activity suggests that the internet may be a 
valuable resource to reach target populations, with digital marketing being an effective strategy in 
driving individuals to visit the website.   
Between August 2018 and February 18, 2020, the NYMAC Genetic Services Referral 
Phone line was underutilized, receiving 67 calls in total. This low call volume was surprising, 
  64 
given the heightened website activity observed during active marketing campaigns, as well as the 
findings of NYMAC’s regional needs assessment (unpublished data, 2015) and prior studies 
indicating lack of awareness of genetic services1,11,16; however, this discordance follows trends 
reported in other phone line evaluation studies.52 Also of note, the majority of callers (74.6%) were 
not connected to a NYMAC staff member or to the phone line voicemail service at the time of 
their call, which was either due to the caller hanging up and choosing not to navigate through the 
phone tree, or unknown technical issues with the phone line itself. The fact that the phone line did 
receive calls during this time frame implies that it is a resource that is perceived as useful by at 
least some individuals in the region; however, the lack of completed phone calls suggests that some 
aspect(s) of the phone line protocol continued to act as a barrier for callers. Similar healthcare 
resource hotlines have also experienced underutilization during initial implementation, but found 
increased success with an expanded implementation time line as well as geographical reach.51,53 
The phone line was only marketed to some MUA/Ps within the NYMAC region, and therefore, 
additional efforts may be needed to implement the phone line on a larger scale regionally before 
similar uptake and utilization trends are seen.   
As illustrated in Table 3, not all telephone and email inquiries were provided with referrals 
in the form of contact information for a genetic service location(s) or other support resource(s). 
For the inquiries which came in via email, the most common reason for not making a referral was 
lack of email response containing information needed to identify relevant genetic services from 
the original person submitting the email inquiry. For the inquiries made via phone, referral success 
was limited by what information the caller was hoping to receive from the phone line. Interestingly, 
three callers contacted the phone line hoping for more information related to ancestry and/or DTC 
testing. While there are genetic services and resources within the region that are available to these 
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individuals, all three declined a referral. NYMAC had not predicted this area of service need during 
phone line development and implementation, and the growing interest in DTC testing in today’s 
society,41,46 as well as these phone line calls, preliminarily suggest that resource development 
focused on information about DTC and ancestry testing may be helpful to individuals and 
healthcare providers in the region.  
Phone calls appeared to cluster on days of the week where phone line staff were most 
available; however, this may be due to phone line hours being listed on website. For example, if 
the phone line was “open,” then someone may have been more likely to call on that day/time. 
Based on the current call patterns, it appears the addition of weekend and early morning hours 
would not provide any additional benefit.  The addition of more evening hours may increase phone 
line availability for individuals who prefer to call during available hours and not leave a voice 
message.  
Like the NYMAC website analytics, the reach of the marketing campaigns can be 
interpreted as somewhat successful, as the digital advertisements led to more NYMAC website 
and phone line webpage clicks. However, the ratio of website clicks to impressions delivered was 
approximately 0.5% or less for social media and web banners, and approximately 2.8% for internet 
search engine advertisements, suggesting that digital marketing provided some success, but may 
not be the best approach to reach the target population. Email marketing was also largely 
ineffective, with only 6.7% of healthcare providers opening the email and generating only one 
(potentially two) call to the phone line. With email increasing as a common method of 
communication79, it may not be the best way to market this type of resource, as there stands to be 
a risk of it getting deleted without being opened. While incomplete at the time of this project’s 
completion, the most recent marketing campaign targeted towards individuals living in MUA/Ps 
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in New York State showed similar trends to the prior marketing campaign. At the time of project 
completion, NYMAC phone line webpage activity continued to increase, and multiple call and 
email inquiries had been received.  
3.4.2  Provider Perspectives 
Interviews with PCPs in the NYMAC region provided valuable insight into perceived 
barriers to access to genetic services in the region, resource needs for PCPs, and provider opinions 
about the phone line and implementation process. All providers interviewed reported practicing in 
medically underserved areas or reported that they would consider at least some of their patient 
population as underserved, making them uniquely situated to weigh in on the state of barriers and 
access to genetic services for MUA/Ps in the NYMAC region. These interviews identified 
common themes and PCP perceptions, including those falling under the categories of patient- and 
provider-related barriers to genetic services, NYMAC phone line, and additional resource 
suggestions.  
Prior studies amongst healthcare providers and patients in rural or underserved areas have 
found appointment wait times, cost, location/distance to services, and lack of knowledge and 
awareness as some perceived barriers to patients accessing genetic services.1,2,14–18 This project 
had similar findings, with PCPs having concerns about the time it takes for individuals to get an 
appointment with a genetic service provider, with one provider attributing this to the workforce 
shortage of healthcare providers trained in genetics, including genetic counselors.9,10 As with other 
studies,13 the PCPs interviewed for this project also felt that the patient populations they serve may 
have more pressing health concerns, may not have a good understanding of the utility or relevance 
of a genetics appointment, or may have some uncertainty about what warrants a genetics 
  67 
appointment. These patient-related barriers may have impacted the utilization of the phone line, 
should potential patients not appreciate the relevance or necessity of a genetics referral, then they 
may be unlikely to utilize a resource that can help facilitate such a referral.  
Interviews were also helpful in identifying provider-related barriers to facilitating patient 
access to genetic services. The provider-related barriers are congruent with findings from other 
studies, and included provider knowledge/understanding of genetics and importance of genetics 
education early in medical training.32,35–37,43 When providers are uncomfortable or unable to 
identify patients who may benefit from a genetics referral, then they too may be less likely to 
utilize the phone line as a resource. This suggests the importance of focusing efforts on providing 
primary care and other healthcare providers with education and resources that can help them 
properly support and identify individuals who may benefit from a genetics referral. 
Regarding the NYMAC phone line and implementation process, all PCPs interviewed 
reported viewing the phone line as a good resource but had varying ideas of how they would 
approach phone line utilization. Two of the PCPs interviewed felt like their role as a PCP was to 
facilitate a genetics referral, and they would not be comfortable directing patients to the NYMAC 
phone line, but rather, would utilize it themselves to obtain information to provide to patients. 
Conversely, the other two PCPs felt that the phone line could be a useful resource for their patients 
and would be comfortable providing patients with information about the phone line if they were 
interested in pursuing genetic services. While the four PCPs interviewed reported seeing the 
benefit of utilizing a resource like the phone line for themselves, none had used the NYMAC phone 
line, and did not feel that they would. The common theme associated with this lack of utilization 
was existing resources. Similar reasoning was provided by healthcare providers in a study 
evaluating an underutilized HIV information hotline in Africa50, and in a prior qualitative study by 
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Carroll et al., which found that healthcare providers felt that having a “go-to” person or resource 
would be helpful to them, and increase their comfort level with personalized medicine.41 The PCPs 
interviewed as part of this project interestingly had similar sentiments, citing existing relationships 
and access to alternate resources and information would provide them with the same benefit as 
potential phone line utilization. The preference for local and/or existing resources suggests the 
importance of establishing resources for MUA/Ps, which likely have few existing genetics 
resources for individuals and healthcare providers living and practicing in these areas. 
As with prior studies1,22,23, resources that the PCPs interviewed felt they would utilize to 
decrease barriers to genetic services included telemedicine, as well as easily accessible resources 
integrated into EHRs. Two providers also suggested a somewhat expanded phone line scope; rather 
than providing location-based referral services, they felt it would be helpful if there was a staffed 
phone line readily available for patients to have a telephone consultation with a genetics provider, 
or for providers to consult with genetics providers about a case in real time. These suggestions can 
be valuable in the future, as NYMAC and the larger genetics community continue to explore 
alternate models to increase access to genetics services19, and NYMAC continues working towards 
the goal of increasing access to genetic services in underserved areas/populations in the new grant 
cycle. 
3.4.3  Project Limitations 
This project had several limitations. Analysis was limited by the small number of calls and 
emails received by the NYMAC Genetic Services Referral Phone Line, as well as the availability 
of complete data from phone and email inquiries received. Because targeted marketing campaigns 
were launched in only three states within the NYMAC region, the findings of this project may not 
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be generalizable to the entire region, as the genetic services and resources, as well as the proportion 
of MUA/Ps varies from state to state. In addition, the phone line marketing campaigns relied on 
location-targeted social media and search engine advertising. This marketing strategy assumes that 
the target population(s) are active on social media, that genetics is a relevant concern for them, 
and that they are interested in locating genetic services. Analysis of the most recent marketing 
campaign in New York State was also limited, as it was not yet completed at the time of data 
analysis. 
The sample size for provider interviews was also small, and a larger sample size may be 
beneficial for more in-depth thematic analysis. The providers who agreed to participate in 
qualitative interviews may have been biased, as those invited were either already familiar with 
NYMAC and the phone line, or practiced in Pittsburgh, Pennsylvania, a city with genetic services 
available across multiple health systems. In addition, only one PCP interviewed practiced in a state 
where a phone line marketing campaign had been implemented. Additionally, the perceptions of 
those providers who did agree to participate in interviews may be inherently different than those 
of the providers who did not agree to participate in interviews. Also, these perceptions may not be 
generalizable to PCPs practicing in other states within the NYMAC region. 
3.4.4  Future Directions 
Based on the overall low utilization of the NYMAC Genetic Services Referral Phone Line, 
a telephone-based service may not meet the current needs of MUA/Ps in the NYMAC region. At 
the end of the current funding cycle (May 31, 2020), the NYMAC Genetic Services Referral Phone 
line will no longer be active. Analysis of phone line utilization and reach of the marketing 
campaigns following its complete implementation would be helpful in determining the overall 
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impact of the phone line and number individuals assisted in the NYMAC region. After official 
launch of the completed web-based ACMG genetic services directory, analysis of this service’s 
website activity may also provide additional information for NYMAC, as well as the other RGNs, 
regarding utilization of an online-based genetic services location resource. 
Based on the increased NYMAC website activity during active marketing campaigns, it 
may be useful for NYMAC to focus some effort to developing online resources for patients and 
healthcare providers. The current evaluation suggests that digital marketing may be necessary to 
raise awareness about the website, and it may be beneficial to consider future marketing strategies 
for NYMAC. Interviews completed with PCPs as part of this project suggest that resources that 
are easily accessible are preferred, and that online educational resources for both healthcare 
providers and individuals/consumers could also work towards addressing barriers to genetic 
services. As the interviews completed as part of this project were a pilot, additional interviews, 
surveys, or focus groups involving more PCPs, as well as other healthcare providers, individual 
consumers, or other potential stakeholders could provide valuable information about perceptions 
of genetic services in the region and resource needs across the region. Continuing efforts to expand 
telemedicine/telegenetics services in the NYMAC region will also likely be beneficial in helping 
to increase access to genetic services for populations in need. 
3.5 Conclusion 
This project was successful in describing the implementation process for the NYMAC 
Genetic Services Referral Phone Line and assessing phone line utilization from August 2018 
through February 2020. Evaluation of phone line use and targeted marketing campaign reach 
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showed an increase in NYMAC website activity and phone line usage during times of active 
marketing campaigns, with a notable decrease in activity when the phone line was not being 
marketed, suggesting that advertising to raise awareness of the service was an integral part of 
phone line implementation. Despite the increased phone line activity surrounding marketing 
campaigns, phone line utilization remained low, with NYMAC staff handling less than twenty 
phone and email inquiries over an 18-month time period. The discordance between increased 
phone line website activity and consistently low call volume suggests that the individuals for 
whom the phone line was designed to serve may prefer getting their information via other means. 
Thematic analysis of qualitative PCP interviews also suggested additional healthcare provider-
related barriers that may have impacted utilization of the phone line, most notably provider 
education and understanding of genetics and genetic services.    
While this quality improvement assessment project was small in size, and limited to only 
parts of the NYMAC region, results can be helpful in guiding future NYMAC efforts to address 
barriers and increase access to genetic services. Although low, utilization of the phone line to date 
suggests that the Genetic Services Referral Phone Line has the potential to be a helpful resource; 
however, strategies to reduce other barriers which impact access to genetic services may need to 
be addressed before such a phone line could function at its full potential. Future studies involving 
individuals, healthcare providers, and genetics professionals may be warranted to determine 
appropriate next steps in NYMAC resource development to continue to work towards increased 
access to genetic services, especially for individuals in the NYMAC region.   
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4.0 Research Significance to Genetic Counseling and Public Health 
This project evaluated the implementation process and utilization of the NYMAC Genetic 
Services Referral Phone Line, a resource developed with an overarching goal of connecting 
individuals in medically underserved areas with genetic services. The development and 
implementation of the phone line, as well as much of the efforts coordinated by NYMAC, the 
NCC, and the RGNs, are of significance to the fields of genetic counseling and public health.  
Maintained and published by the Accreditation Council for Genetic Counseling, the 
Practice-Based Competencies for Genetic Counselors outlines twenty-two competencies that all 
genetic counselors must demonstrate.80 In addition to having adequate knowledge of genetics, 
psychosocial counseling skills, and effective educational strategies, all genetic counselors must 
“[a]dvocate for individuals, families, communities and the genetic counseling profession,” with 
this advocacy role notably including a need to “employ strategies that to increase/promote access 
to genetic counseling services.”80  
Improving access to genetic services can allow more individuals to benefit from a 
discussion with a trained genetics professional, which has been shown to lead to increased positive 
outcomes. Outcomes-based studies, primarily in the cancer genetics setting, focused on the impact 
of genetic counseling have suggested that individuals who receive genetic counseling often have 
increased knowledge about genetics and/or genetic testing when compared to individuals who did 
not receive genetic counseling.81 With unique training to provide both education and psychosocial 
support, genetic counselors can impact many aspects of patient experience. Studies have also 
shown that genetic counseling is associated with more accurate risk perception, increased patient 
satisfaction, and positive changes in health behaviors, including management recommendation 
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adherence.81 The availability of genetic counseling has also been associated with increased patient 
engagement which results in better health outcomes.82  
The findings of this evaluation project may help genetic counselors and other genetics 
professionals better understand barriers to genetic services, as well as potential interventions to 
address these barriers. In continuing efforts to develop interventions and resources to engage 
patients and providers and increase access to genetic services, this project can provide insight as 
to interventions, such as the phone line, which may not be appropriate for targeting underserved 
populations, as well as efforts to focus on, such as telegenetics and provider education. 
Increasing access to genetic services across the nation is the NCC’s overarching goal, and 
thus, the goal of NYMAC and the other RGNs. With the implementation of the NYMAC Genetic 
Services Referral Phone Line as a prospective way to connect medically underserved individuals 
with relevant genetic services, this goal directly ties into the three core functions of public health 
and essential public health services.83 NYMAC’s projects, including the phone line, fulfill all three 
core functions of public health: assessment, policy development, and assurance.83 NYMAC is 
continuously working to identify and explore genetic health concerns within the region, as well as 
working towards solutions for those concerns within the region, encompassing the assessment 
function of public health. This project, as it relates to understanding barriers related to accessing 
genetics services, ties into the investigation portion of the essential public health services. In 
addition, using partnerships with community resources and regional healthcare providers, 
NYMAC has developed and implemented a variety of resources and interventions, including the 
phone line, to address barriers and other health-related concerns for individuals living in the region.  
NYMAC has also been involved in execution of policies and interventions designed to 
protect public health, correlating with the policy development function of public health.  Most 
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notably, the implementation of the Genetic Services Referral Phone line directly relates to the 
assurance function of public health. The phone line was designed to link individuals within the 
region, especially in underserved areas, with genetic services, an essential public health service. 
This project specifically relates to the public health service of evaluation by assessing the 
effectiveness of the phone line and other related resources currently available. Through this 
project, NYMAC has gained insight from utilization evaluation and healthcare provider 
perceptions that can influence future efforts to address regional barriers to genetic services. 
Addressing barriers and increasing access to genetic services for individuals in MUA/Ps 
can likely not be achieved by one group or addressed with one single intervention. However, 
through collaborative efforts between groups like NYMAC, the other RGNs and the NCC, as well 
as genetic counselors, patients, other healthcare providers and stakeholders, resource and 
intervention development can continue, and these efforts can continue to work towards making 
genetic services accessible to all patients. 
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Appendix A University of Pittsburgh IRB Approval 
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Appendix B NYMAC Social Media Marketing Campaign Image Examples 
 
 
 
Figure 6. Social Media Advertisement Examples - Link to Website 
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Figure 7. Search Engine Advertisement Examples 
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Appendix C MUA/Ps Targeted in Initial Market Campaign 
State Counties Marketing Campaign Dates 
Maryland 
Anne Arundel 
Baltimore 
Baltimore City 
Caroline 
Dorchester 
Somerset 
Talbot 
Wicomico 
Worcester 
January 7, 2019 – May 31, 2019 
Delaware 
Kent 
Sussex 
March 1, 2019 – May 31, 2019 
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Appendix D NYMAC Provider Email Campaign Message 
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Appendix E Provider Interview Email Invitation 
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Appendix F Semi-Structured Interview Questions 
o Can you tell me what type of healthcare provider you are and what practice area or specialty 
you practice in? 
o How would you describe the area/patients that you serve? 
• Would you say that you practice in a medically underserved area? 
o Have you referred patients to genetic services? 
• Would you say this is something you do routinely? 
• What sort of patients do you refer to genetics? 
• Can you tell me about any difficulties or barriers you’ve experienced in making a 
genetics referral? 
▪ What type of resources do you think would be helpful to address these 
barriers? 
• Can you identify any additional barriers to your patients getting genetic services? 
o Were you familiar with the NYMAC Genetic Services Referral Phone Line prior to being 
contacted for this interview?  
• If so, how did you come to hear about it? 
o Have you, or would you utilize the phone line as a resource for yourself? For example, you 
call us to find a genetic service for a patient.  
• Why or why not? 
• If no, what do you think would be a better resource for you? 
o Have you, or would you utilize the phone line as a resource for your patients? For example, 
you provide information about the phone line to a patient to call us to find genetic services 
themselves. 
• Why or why not? 
• If no, what do you think would be a better resource for your patients? 
o What are your thoughts about the phone line model as it stands currently? 
o Have you had a chance to visit the NYMAC/Phone Line website? 
• If so, do you feel like it provides helpful information? 
▪ If no, what would you like to see included on this website? 
o Do you have any additional thoughts on potential ways to address barriers to genetic 
services?  
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Appendix G NYMAC Website Analytics 
 
Figure 8. NYMAC Website Analytics 08/01/2018 - 01/06/2019 
 
 
Figure 9. NYMAC Website Analytics 01/07/2019 - 05/31/2019 
540
(28.5%)
1124
(59.3%)
194
(83.6%)
38
(16.4%)
Phone Line
Page Views
232
(12.2%)
08/01/2018 - 01/06/2019
(No Marketing)
NYMAC Homepage Views Other Website Activity Unique Views Duplicate Views
685
(2.8%)
2800
(11.6%)
19233
(93.2%)
1405
(6.8%)
Phone Line
Page Views
20638
(85.6%)
01/07/2019 - 05/31/2019
(Maryland and Delaware Marketing)
NYMAC Homepage Views Other Website Activity Unique Views Duplicate Views
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Figure 10. NYMAC Website Analytics 06/01/2019 - 01/05/2020 
 
 
Figure 11. NYMAC Website Analytics 01/06/2020 - 02/18/2020 
 
 
 
 
703
(28.97%)
1356
(55.87%)
315
(85.6%)
53
(14.4%)
Phone Line
Page Views
368
(15.16%)
06/01/2019 - 01/05/2020
(No Marketing)
NYMAC Homepage Views Other Website Activity Unique Views Duplicate Views
1510
(5.1%)
4545
(15.2%)
22069
(92.9%)
1683
(7.1%)
Phone Line
Page Views
23752
(79.7%)
01/06/2020 - 02/18/2020
(New York Marketing)
NYMAC Homepage Views Other Website Activity Unique Views Duplicate Views
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